Medicines Shortages Update
Last Updated 14 August 2026
NOTE: For any reimbursement queries relating to EMPs please contact PCRS – ExemptMed@hse.ie.
| Tradename | Pack Size | GMS No | Expected Resupply Date | Manufacturer | Date Notified | Date Last Updated | Date Resolved | Reason | Generic Name | Note | Reimbursement of EMP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ACETYLCYSTEINE ESSENTIAL 600MG EFF TABS | 30TABS | 64004 | 31st August 2026 | ASCOT LABS | 18-Jun-24 | 20-May-26 | No reason provided | ACETYLCYSTEINE | As per HPRA | EMP reimbursed for duration of HPRA registered shortage | |
| ACIDEX LIQUID ORAL SUSPENSION | 200ML | Unable to provide date | PINEWOOD | 23-Jan-25 | 14-Jan-26 | Reformulation / regulatory issue | SOD ALG/SOD H CARB/CACARB | As per Pinewood | |||
| ACIDEX LIQUID ORAL SUSPENSION | 500ML | Unable to provide date | PINEWOOD | 23-Jan-25 | 14-Jan-26 | Reformulation / regulatory issue | SOD ALG/SOD H CARB/CACARB | As per Pinewood | |||
| ADDIPHOS CONC FOR SOLN/INF 20ML POA | 10VIAL | In Stock | FRES KABI | 12-Jan-26 | 31-Jul-26 | 30-Jul-26 | API shortage/ unavailability | POTASSIUM/PHOSPHAT/SODIUM | No longer on HPRA list | ||
| ADENOCOR 3MG/ML SOLN FOR INJ 2ML | 6VIAL | TBC | SANOFI AVE | 12-May-26 | Managing remaining stocks until next resupply | ADENOSINE | As per Sanofi | ||||
| ADENOSINE 3MG/ML SOLN/INJ PFS 4ML POA | 10PACK | 30th September 2026 | FRES KABI | 29-May-26 | 29-Jun-26 | Unexpected increased demand | ADENOSINE | As per HPRA | |||
| ADRENALINE EPINEPHRINE 1:1000 INJ 1ML | 10AMP | BSR available. No confirmed timeline at the moment on the IE packs. No shortage listed on HPRA list 04.08.26 | ADVANZ | 05-Jun-26 | 04-Aug-26 | Unexpected increased demand | EPINEPHRINE | As per Advanz | |||
| AIRBUFO FORSPIRO 320MCG/9MCG 60 DOSE | 1INHLR | 69933 | Back In Stock | ROWA | 22-Jun-26 | 17-Jul-26 | 17-Jul-26 | Delayed delivery | BUDESONIDE/FORMOTEROL | As per Rowa | Not reimbursed - alternative therapeutic options available on the reimbursement list |
| ALDACTONE 100MG FC TABS | 28TABS | 79782 | OOS expected 17th August. Return date 21st September 2026 | PFIZER | 03-Aug-26 | 11-Aug-26 | Unexpected increased demand | SPIRONOLACTONE | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| ALENDRONATE/COLECA TEVA 70MG/2800IU TABS | 4TABS | 13480 | Sep-26 | TEVA | 27-Apr-26 | 08-Jun-26 | Manufacturing delay | ALENDRONIC AC/COLECALCIFE | As per Teva | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| ALPRAZOLAM 0.5MG TABS | 100TABS | 15917 | Mid August 2026 | ROWA | 08-Jun-26 | 10-Jul-26 | Increase in sales | ALPRAZOLAM | As per Rowa | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| AMLODIPINE TEVA 10MG TABS | 28TABS | 15079 | Aug-26 | TEVA | 26-Jun-26 | 30-Jul-26 | Manufacturing delay | AMLODIPINE | As per Teva | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| AMLODIPINE/VALSARTAN MYLAN 10/160MG TAB | 28TABS | 24533 | 30th November 2026 | VIATRIS | 26-Nov-25 | 08-Jun-26 | Manufacturing delay | AMLODIPINE/VALSARTAN | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| AMLODIPINE/VALSARTAN MYLAN 5MG/160MG TAB | 28TABS | 24532 | 2nd November 2026 | VIATRIS | 28-Apr-26 | 08-Jun-26 | Manufacturing delay | AMLODIPINE/VALSARTAN | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| AMOROLFINE 5%W/V MEDICATED NAIL LACQUER | 5ML | 31464 | Jan-27 | ROWA | 06-Feb-26 | 27-Jul-26 | Manufacturing delay | AMOROLFINE | As per Rowa | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| ANAPEN 300MCG/0.3ML SOLN/INJ ADULT PFS | 2SYR | 13237 | In Stock | LINCOLNMED | 23-Jul-26 | 14-Aug-26 | 14-Aug-26 | Unexpected increased demand | EPINEPHRINE | No longer on HPRA list | Not reimbursed - alternative therapeutic options available on the reimbursement list |
| ANAPEN 500MCG/0.3ML SOLN/INJ ADULT PFS | 2SYR | 39108 | 1st January 2027 | LINCOLNMED | 04-Sep-24 | 24-Jul-26 | Manufacturing issues | EPINEPHRINE | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| ANTI-HIST ALLERGY 1MG/ML ORAL SOLUTION | 200ML | End August 2026 | CLONMEL | 10-Apr-26 | 05-Aug-26 | Manufacturing delay | CETIRIZINE | As per Clonmel | |||
| APREPITANT ACCORD 125MG HARD CAPS | 5CAPS | 28903 | TBC Further Delays | ACCORD HC | 04-Feb-26 | 07-Aug-26 | Manufacturing delay | APREPITANT | As per Accord | Considered on a patient specific basis | |
| APREPITANT ACCORD 125MG/80MG CAPS 3 DAY | 1PACK | 28906 | TBC Further Delays | ACCORD HC | 18-Feb-25 | 07-Aug-26 | Manufacturing delay | APREPITANT | As per Accord | Considered on a patient specific basis | |
| APREPITANT ACCORD 80MG HARD CAPS 2 DAY | 1PACK | 28904 | TBC Further Delays | ACCORD HC | 12-May-25 | 07-Aug-26 | Manufacturing delay | APREPITANT | As per Accord | Considered on a patient specific basis | |
| ARIPIL 5MG FC TABS DONEPEZIL | 28TABS | 12275 | 1st January 2027 | VIATRIS | 18-Feb-26 | 25-May-26 | Unexpected increased demand | DONEPEZIL | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| ARTHROTEC 50MG MOD REL TABS | 60TABS | 13102 | Mid August 2026 | PFIZER | 18-May-26 | 08-Jul-26 | Manufacturing delay | DICLOFENAC SOD/MISOPROSTO | As per Pfizer | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| ASACOLON 800MG GAST RES TABS | 90TABS | 14325 | In Stock | TILLOTTS | 20-Jul-26 | 31-Jul-26 | 30-Jul-26 | Manufacturing delay | MESALAZINE | No longer on HPRA list | Not reimbursed - alternative therapeutic options available on the reimbursement list |
| ATGAM 50MG/ML CONC/SOLN/INF 5ML POA | 5AMP | OOS expected 17th August. Expected return date 26th October 2026 | PFIZER | 07-Aug-26 | Unexpected increased demand | ANTITHYMO IMMUNOGLOB EQUI | As per HPRA | ||||
| ATOMOXETINE ACCORD 100MG HARD CAPS | 28CAPS | 36009 | TBC Further Delays | ACCORD HC | 06-Jun-24 | 07-Aug-26 | Manufacturing delay | ATOMOXETINE | As per Accord | EMP reimbursed for duration of HPRA registered shortage | |
| ATOMOXETINE ACCORD 10MG HARD CAPS | 28CAPS | 36001 | TBC Further Delays | ACCORD HC | 06-Jun-24 | 07-Aug-26 | Manufacturing delay | ATOMOXETINE | As per Accord. | EMP reimbursed for duration of HPRA registered shortage | |
| ATOMOXETINE ACCORD 10MG HARD CAPS | 7CAPS | 36000 | Nov-26 | ACCORD HC | 06-Jun-24 | 22-May-26 | Manufacturing delay | ATOMOXETINE | As per Accord | EMP reimbursed for duration of HPRA registered shortage | |
| ATOMOXETINE ACCORD 18MG HARD CAPS | 28CAPS | 36002 | TBC Further Delays | ACCORD HC | 28-Jul-26 | 07-Aug-26 | Manufacturing delay | ATOMOXETINE | As per Accord | EMP reimbursed for duration of HPRA registered shortage | |
| ATOMOXETINE ACCORD 25MG HARD CAPS | 28CAPS | 36005 | TBC Further Delays | ACCORD HC | 06-Jun-24 | 07-Aug-26 | Manufacturing delay | ATOMOXETINE | As per Accord | EMP reimbursed for duration of HPRA registered shortage | |
| ATOMOXETINE ACCORD 25MG HARD CAPS | 7CAPS | 36004 | TBC Further Delays | ACCORD HC | 06-Jun-24 | 07-Aug-26 | Manufacturing delay | ATOMOXETINE | As per Accord | EMP reimbursed for duration of HPRA registered shortage | |
| ATOMOXETINE ACCORD 40MG HARD CAPS | 28CAPS | 36006 | TBC Further Delays | ACCORD HC | 28-Jul-26 | 07-Aug-26 | Manufacturing delay | ATOMOXETINE | As per Accord | EMP reimbursed for duration of HPRA registered shortage | |
| ATOMOXETINE ACCORD 80MG HARD CAPS | 28CAPS | 36008 | Pending | ACCORD HC | 28-Jul-26 | 05-Aug-26 | Manufacturing delay | ATOMOXETINE | As per HPRA | EMP reimbursed for duration of HPRA registered shortage | |
| ATORVASTATIN 20MG FC TABS | 28TABS | 41938 | Oct-26 | ACCORD HC | 13-Jul-26 | 07-Aug-26 | Manufacturing delay | ATORVASTATIN | As per Accord | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| ATORVASTATIN VIATRIS 20MG FC TABS | 28TABS | 41966 | No back in stock date available at the moment | VIATRIS | 07-Apr-25 | 20-May-26 | Manufacturing delay | ATORVASTATIN | As per Viatris. HPRA shows return date as Pending | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| ATORVASTATIN VIATRIS 40MG FC TABS | 28TABS | 41967 | No back in stock date available at the moment | VIATRIS | 21-Mar-25 | 20-May-26 | Manufacturing delay | ATORVASTATIN | As per Viatris | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| ATORVASTATIN VIATRIS 80MG FC TABS | 28TABS | 41968 | No back in stock date available at the moment | VIATRIS | 14-Apr-25 | 20-May-26 | Manufacturing delay | ATORVASTATIN | As per Viatris | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| ATOZET 10MG/10MG FC TABS | 30TABS | 36858 | In Stock | ORGANON | 13-Jul-26 | 13-Aug-26 | 13-Aug-26 | Unexpected increased demand | EZETIMIBE/ATORVASTATIN | No longer on HPRA list | Not reimbursed - alternative therapeutic options available on the reimbursement list |
| ATOZET 10MG/10MG FC TABS IMED | 30TABS | No return date | IMED | 20-Jan-26 | 20-Apr-26 | Commercial issues | EZETIMIBE/ATORVASTATIN | As per IMED | |||
| ATOZET 10MG/20MG FC TABS | 30TABS | 36859 | In Stock | ORGANON | 13-Jul-26 | 05-Aug-26 | 05-Aug-26 | Unexpected increased demand | EZETIMIBE/ATORVASTATIN | No longer on HPRA list | Not reimbursed - alternative therapeutic options available on the reimbursement list |
| ATOZET 10MG/40MG TABS IMED | 30TABS | No return date | IMED | 20-Jan-26 | 20-Apr-26 | Commercial issues | EZETIMIBE/ATORVASTATIN | As per IMED | |||
| ATOZET 10MG/80MG FC TABS | 30TABS | 36863 | 27th August 2026 | ORGANON | 16-Jun-26 | 07-Jul-26 | Unexpected increased demand | EZETIMIBE/ATORVASTATIN | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| ATOZET 10MG/80MG TABS IMED | 30TABS | No return date | IMED | 20-Jan-26 | 20-Apr-26 | Commercial issues | EZETIMIBE/ATORVASTATIN | As per IMED | |||
| ATRACURIUM BESILATE 10MG/ML 2.5ML | 5VIAL | Awaiting update | CARAGEN | 17-Jan-25 | 27-Jul-26 | Awaiting information | ATRACURIUM | As per Caragen | |||
| AUGMENTIN 875MG/125MG FC TABS | 14TABS | 13428 | 31st August 2026 | GSK MED | 30-Jun-26 | 11-Aug-26 | Unexpected increased demand | CO-AMOXICLAV | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| AVODART 0.5MG SOFT CAPS IMED | 30CAPS | 53675 | w/e 9th August 2026 | IMED | 05-Aug-26 | 11-Aug-26 | No reason provided | DUTASTERIDE | As per IMED - expecting 300 units to be available for sale before the end of this week, with another 150 units confirmed in transit from suppliers due later in the month. | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| AZACITIDINE ACCORD 25MG/ML PDR/SUSP/INJ | 1VIAL | No return date (150ML) | ACCORD HC | 26-Mar-26 | 21-Apr-26 | Reason provided | AZACITIDINE | As per Accord | |||
| AZITHROMYCIN TEVA 250MG FC TABS | 6TABS | 16198 | Back In Stock | TEVA | 12-Jun-26 | 30-Jul-26 | 30-Jul-26 | Manufacturing delay | AZITHROMYCIN | As per Teva | Not reimbursed - alternative therapeutic options available on the reimbursement list |
| AZROMAX 250MG FC TABS AZITHROMYCIN | 6TABS | 13822 | 2nd November 2026 | VIATRIS | 31-Jul-26 | 11-Aug-26 | Unexpected increased demand | AZITHROMYCIN | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| BENDAMUSTINE 100MG PDR/CONC/SOLN FOR INF | 5VIAL | No return date | ACCORD HC | 23-Jan-25 | 27-Mar-26 | No reason pprovided | As per Accord | ||||
| BENDROFLUMETHIAZIDE 2.5MG TABS | 28TABS | 36979 | Q4 2026 | AZURE | 28-Jan-25 | 20-May-26 | Undergoing testing | BENDROFLUMETHIAZIDE | As per Azure (HPRA shows 31.10.26 return date) | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| BENDROFLUMETHIAZIDE 5MG TABS | 28TABS | 36980 | Q4 2026 | AZURE | 16-Jul-25 | 20-May-26 | Delay in securing EU QP release services | BENDROFLUMETHIAZIDE | As per Azure (HPRA shows 31.10.26 return date) | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| BENZYL BENZOATE 25% APPLICATION CUT EMUL | 150ML | Pending | GRDNR FAM | 31-Jul-25 | 05-Feb-26 | API shortage / unavailability | BENZYL BENZOATE | As per HPRA 05.02.26 | |||
| BETNESOL 0.1% EYE EAR & NOSE DROPS | 10ML | 15113 | Pending | RPH | 29-Apr-26 | 26-Jun-26 | Manufacturing delay | BETAMETHASONE SODIUM PHOS | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| BETNESOL N EYE EAR & NASAL DROPS | 10ML | 15121 | Pending | RPH | 01-May-26 | 25-Jun-26 | Manufacturing delay | BETAMETHASON NA PHOS/NEOM | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| BETNOVATE 0.1% OINTMENT | 100G | 62146 | 1st September 2026 | GSK MED | 22-Jun-26 | 11-Aug-26 | Unexpected increased demand | BETAMETHASONE VALERATE | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| BRILLPHALAC 3.335G/5 ML ORAL SOLUTION | 300ML | Q4 2026 | WINDZOR PH | 17-Feb-25 | 07-Jul-26 | Change of manufacturing site | LACTULOSE | As per Windzor. HPRA shows pending return date | |||
| BRILLPHALAC 3.335G/5 ML ORAL SOLUTION | 500ML | 67152 | Q4 2026 | WINDZOR PH | 17-Feb-25 | 07-Jul-26 | Change of manufacturing site | LACTULOSE | As per Windzor. HPRA shows pending return date | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| BRINAVESS 20MG/ML CONC FOR SOLN/INF 25ML | 1VIAL | No confirmed timeline (UK packs may be avail) | ADVANZ | 17-Nov-25 | 30-Mar-26 | Regulatory issue | VERNAKALANT | As per Advanz (ULM UK packs may be avail). HPRA shows 31.12.26 return date | |||
| BROLENE 0.1% EYE DROPS SOLN | 10ML | Early October 2026 | CLONMEL | 21-May-26 | 07-Jul-26 | Manufacturing delay | PROPAMIDINE | As per Clonmel | |||
| BUDESONIDE TEVA PHARM 0.5MG/2ML NEB SUSP | 20NEB | 76605 | Aug-26 | TEVA | 04-Dec-24 | 25-Jun-26 | Manufacturing delay | BUDESONIDE | As per Teva | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| BUDESONIDE TEVA PHARMA 1MG/2ML NEB SUSP | 20NEB | 13341 | Sep-26 | TEVA | 02-Jan-25 | 09-Jul-26 | Manufacturing delay | BUDESONIDE | As per Teva | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| BURINEX 1MG TABS | 30TABS | 31596 | 1st October 2026 | KARO | 31-Oct-25 | 05-Aug-26 | Manufacturer cannot supply | BUMETANIDE | As per HPRA. (On allocation when in stock). Where an EMP does not have an assigned administrative GMS code, as in this case, pharmacies should use the appropriate 777- claiming code for DPS, LTI and HAA patients. For GMS patients, reimbursement may be available through the Discretionary Hardship Arrangement, subject to approval. | EMP reimbursed for duration of HPRA registered shortage. Where an EMP does not have an assigned administrative GMS code, as in this case, pharmacies should use the appropriate 777- claiming code for DPS, LTI and HAA patients. For GMS patients, reimbursement may be available through the Discretionary Hardship Arrangement, subject to approval. | |
| CALCIPOTRIOL/BETAMETH 50MCG+0.5MG/G OINT | 30G | 31599 | OOS expected w/c 17th August. Return date 14th December 2026 | ROWA | 30-Jul-26 | 05-Aug-26 | Increase in sales | CALCIPOTRIOL/BETAMETHASON | As per Rowa | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| CALVEPEN 666MG TABS | 100TABS | 16397 | Back In Stock | CLONMEL | 06-Jul-26 | 24-Jul-26 | 24-Jul-26 | Manufacturing delay | PHENOXYMETHYLPENICILLIN | As per Clonmel | Not reimbursed - alternative therapeutic options available on the reimbursement list |
| CAMPTO 20MG/ML CONC FOR SOLN/INF 5ML | 1VIAL | Early August 2026 | PFIZER | 26-Jun-26 | 08-Jul-26 | Unexpected increased demand | IRINOTECAN | As per Pfizer | |||
| CELEBREX 100MG HARD CAPS | 60CAPS | 17019 | 1st December 2026 | VIATRIS | 13-Jul-26 | 22-Jul-26 | Unexpected increased demand | CELECOXIB | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| CELEBREX 200MG HARD CAPS | 30CAPS | 17066 | OOS expected 17th August. Return date 15th December 2026 | VIATRIS | 03-Aug-26 | 11-Aug-26 | Unexpected increased demand | CELECOXIB | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| CELECOXIB 100MG HARD CAPS | 60CAPS | 13406 | Back In Stock | ACCORD HC | 04-Feb-26 | 07-Aug-26 | 07-Aug-26 | Manufacturing delay | CELECOXIB | As per Accord | Not reimbursed - alternative therapeutic options available on the reimbursement list |
| CELECOXIB 200MG HARD CAPS | 30CAPS | 13407 | 31st August 2026 | ACCORD HC | 04-Feb-26 | 20-Jul-26 | Manufacturing delay | CELECOXIB | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| CELECOXIB KRKA 200MG HARD CAPS | 30CAPS | 13409 | 15th October 2026 | KRKA PHARM | 22-Jul-26 | 06-Aug-26 | Unexpected increased demand | CELECOXIB | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| CHLOROMYCETIN 0.5% REDI-DROPS EYE DROPS | 10ML | 67318 | No confirmed timeline | ADVANZ | 05-Aug-25 | 20-May-26 | Manufacturing issue | CHLORAMPHENICOL | As per Advanz | EMP reimbursed for duration of HPRA registered shortage | |
| CINACALCET ACCORDPHARMA 30MG FC TABS | 28TABS | 89046 | TBC | ACCORD HC | 21-Mar-25 | 20-May-26 | Manufacturing delay | CINACALCET | As per Accord (HPRA shows July 2027 return date) | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| CINACALCET ACCORDPHARMA 60MG FC TABS | 28TABS | 89047 | TBC | ACCORD HC | 21-Mar-25 | 20-May-26 | Manufacturing delay | CINACALCET | As per Accord (HPRA shows July 2027 return date) | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| CINACALCET ACCORDPHARMA 90MG FC TABS | 28TABS | 89048 | TBC | ACCORD HC | 14-Feb-25 | 20-May-26 | No reason provided | CINACALCET | As per Accord (HPRA shows July 2027 return date) | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| CINACALCET CLONMEL 60MG FC TABS | 28TABS | 89015 | Mid August 2026 | CLONMEL | 25-Jun-26 | 24-Jul-26 | Unexpected increased demand | CINACALCET | As per Clonmel | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| CINACALCET TEVA 30MG FC TABS | 28TABS | 89080 | Aug-26 | TEVA | 08-Jun-23 | 08-Jun-26 | No reason provided | CINACALCET | As per Teva. | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| CINACALCET TEVA 60MG FC TABS | 28TABS | 89081 | Sep-26 | TEVA | 27-Jul-23 | 08-Jun-26 | No reason provided | CINACALCET | As per Teva | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| CINACALCET TEVA 90MG FC TABS | 28TABS | 89082 | Sep-26 | TEVA | 03-Aug-23 | 08-Jun-26 | No reason provided | CINACALCET | As per Teva. | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| CIPRAGER 10MG FC TABS CITALOPRAM | 28TABS | 18503 | OOS expected 14th September,. Return date 16th November 2026 | VIATRIS | 07-May-26 | 11-Aug-26 | Manufacturing delay | CITALOPRAM | As per Viatris | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| CIPRAGER 10MG FC TABS CITALOPRAM | 28TABS | 18503 | OOS expected 14th September,. Return date 16th November 2026 | VIATRIS | 07-May-26 | 11-Aug-26 | Manufacturing delay | CITALOPRAM | As per Viattris | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| CIPRAGER 40MG FC TABS CITALOPRAM | 28TABS | 18345 | OOS expected 1st September,. Return date 16th November 2026 | VIATRIS | 07-May-26 | 11-Aug-26 | Manufacturing delay | CITALOPRAM | As per Viatris | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| CIPROFLOXACIN TEVA 500MG FC TABS | 10TABS | 18952 | TBC | TEVA | 21-Nov-24 | 20-May-26 | Capacity issues | CIPROFLOXACIN | As per Teva | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| CIPROFLOXACIN TEVA 500MG FC TABS | 20TABS | 18974 | TBC | TEVA | 27-Feb-25 | 20-May-26 | No reason provided | CIPROFLOXACIN | As per Teva | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| CLARITHROMYCIN 500MG PDR CONC SOLN/INF | 1VIAL | Discontinued | ADVANZ | 09-Feb-26 | 04-Aug-26 | 31-Jul-26 | Prolonged manufacturing issue. | CLARITHROMYCIN | As per Advanz | ||
| CLARITHROMYCIN TEVA 500MG FC TABS | 14TABS | 13003 | OOS expected 16th August 2026. Return date 30th November 2026 | TEVA | 03-Aug-26 | 11-Aug-26 | Manufacturing delay | CLARITHROMYCIN | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| CLONFOLIC 0.4MG TABS | 28TABS | TBC | CLONMEL | 08-Jul-24 | 22-May-26 | Quality issue | FOLIC ACID | As per Clonmel | |||
| CLONFOLIC 0.4MG TABS | 98TABS | 18176 | TBC | CLONMEL | 05-Jul-24 | 22-May-26 | Quality issue | FOLIC ACID | As per Clonmel. | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| CLONOCID 500MG FC TABS CLARITHROMYCIN | 14TABS | 18143 | Back In Stock | CLONMEL | 26-Jan-26 | 24-Jul-26 | 24-Jul-26 | No reason provided | CLARITHROMYCIN | As per Clonmel | Not reimbursed - alternative therapeutic options available on the reimbursement list |
| CO-AMOXICLAV TEVA 1000MG/200MG PDRINJINF | 10VIAL | TBC | TEVA | 18-Jun-26 | 31-Jul-26 | Manufacturing delay | CO-AMOXICLAV | As per Teva. Not expected before 2027 | |||
| CO-AMOXICLAV TEVA 500MG/100MG PDRINJINF | 10VIAL | TBC | TEVA | 08-Mar-24 | 22-Jan-26 | Unexpected increase in demand | CO-AMOXICLAV | As per Teva | |||
| COCOIS OINTMENT | 100G | 18769 | Pending | RPH | 18-Jun-24 | 20-May-26 | Regulatory issue | COAL TAR/SULFUR/SALICYLIC | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| COCOIS OINTMENT | 40G | 18757 | Pending | RPH | 18-Jun-24 | 20-May-26 | Regulatory issue | COAL TAR/SULFUR/SALICYLIC | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| COLOMYCIN 2 MIU PDR FOR SOLN/INJ/INF/INH | 10VIAL | 66035 | Back In Stock | TEVA | 27-May-26 | 13-Aug-26 | 13-Aug-26 | Manufacturing delay | COLISTIMETHATE | As per Teva | Not reimbursed - alternative therapeutic options available on the reimbursement list |
| CORTIMENT 9MG PRO REL TABS | 30TABS | 36833 | In Stock | FERRING | 31-Jul-26 | 11-Aug-26 | 11-Aug-26 | Unexpected increased demand | BUDESONIDE | No longer on HPRA list | Not reimbursed - alternative therapeutic options available on the reimbursement list |
| CRESEMBA 200MG PDR CONC/SOLN/INF | 1VIAL | 9th September 2026 | PFIZER | 27-Jul-26 | 11-Aug-26 | Unexpected increased demand | ISAVUCONAZOLE | As per HPRA | |||
| CRESTOR 20MG FC TABS | 28TABS | 19207 | Mid August 2026 | GRUNENTHAL | 05-Jun-26 | 31-Jul-26 | Manufacturing delay | ROSUVASTATIN | As per Allphar. HPRA shows 11.08.26 return date | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| CYTOTEC 200MCG TABS | 60TABS | 19951 | Mid August 2026 | PFIZER | 11-May-26 | 08-Jul-26 | Unexpected increased demand | MISOPROSTOL | As per Pfizer | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| DAKTARIN 20MG/G ORAL GEL | 40G | 77623 | 2027 | JOHN&JOHN | 19-Mar-26 | 20-May-26 | Quality issue | MICONAZOLE | As per J&J | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| DEPREGER 100MG FC TABS SERTRALINE | 28TABS | 20784 | No back in stock date available at the moment | VIATRIS | 22-Aug-24 | 20-May-26 | No reason provided | SERTRALINE | As per Viatris | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| DEPREGER 50MG FC TABS SERTRALINE | 28TABS | 20713 | No back in stock date available at the moment | VIATRIS | 06-Nov-24 | 20-May-26 | No reason provided | SERTRALINE | As per Viatris | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| DESENEX POWDER | 55G | Early September 2026 | CLONMEL | 20-Jun-25 | 24-Jul-26 | Manufacturing delay | ZINC UNDECYL/UNDECYL ACID | As per Clonmel | |||
| DESFERAL 500MG PDR FOR SOLN FOR INJ | 10VIAL | 20478 | In Stock | MITEM | 27-May-26 | 22-Jul-26 | 20-Jul-26 | Unexpected increased demand | DEFEROXAMINE | No longer on HPRA list | |
| DESOGESTREL ROWEX 75MCG FC TABS | 28TABS | 17963 | OOS expected w/c 17th August. Return date TBC | ROWA | 07-Aug-26 | Increasein sales | DESOGESTREL | As per Rowa | |||
| DESOGESTREL ROWEX 75MCG FC TABS | 84TABS | 33513 | OOS expected w/c 24th August. Return date TBC | ROWA | 13-Aug-26 | Manufacturing delay | DESOGESTREL | As per Rowa | |||
| DETRUSITOL 1MG FC TABS | 56TABS | 53615 | OOS expected 17th August. Return date 16th September 2026 | VIATRIS | 31-Jul-26 | 11-Aug-26 | Unexpected increased demand | TOLTERODINE | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| DETRUSITOL 2MG FC TABS | 56TABS | 53627 | 4th September 2026 | VIATRIS | 31-Jul-26 | 11-Aug-26 | Unexpected increased demand | TOLTERODINE | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| DETRUSITOL SR 2MG PRO REL HARD CAPS | 28CAPS | 53651 | In Stock | VIATRIS | 01-May-26 | 17-Jul-26 | 16-Jul-26 | Unexpected increase in demand | TOLTERODINE | No longer on HPRA list | Not reimbursed - alternative therapeutic options available on the reimbursement list |
| DETRUSITOL SR 4MG PRO REL HARD CAPS | 28CAPS | 53662 | 14th August 2026 | VIATRIS | 01-May-26 | 06-Aug-26 | Unexpected increased demand | TOLTERODINE | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| DEXAMETHASONE PHOS NORIDEM 4MG/ML 1ML | 10AMP | Awaiting update | CARAGEN | 01-Apr-26 | 27-Jul-26 | Manufacturing delay | DEXAMETHASONE PHOSPHATE | As per Caragen | |||
| DICLAC 1% GEL DICLOFENAC | 50G | 22274 | OOS w/c 17th August. Return date 4th October 2026 (estimated) | ROWA | 13-Aug-26 | Increase in sales | DICLOFENAC SODIUM | As per Rowa | |||
| DIPRIVAN 1% EMUL/INJ/INF 50ML PFS | 1SYR | 1st October 2026 | ASPEN | 05-Jun-26 | Manufacturing delay | PROPOFOL | As per HPRA | ||||
| DIPROSALIC SCALP APPLICATION | 100ML | 21474 | OOS expected 23rd August. Return date pending, | ORGANON | 07-Aug-26 | Manufacturing delay | BETAMETHASO DIPRO/SALICYL | As per HPRA | |||
| DONA 1500MG PDR FOR ORAL SOLN SACHET | 30SACH | Pending | COOPER CH | 11-Jun-26 | 18-Jun-26 | Manufacturing delay | GLUCOSAMINE | As per HPRA | |||
| DOXORUBICIN TEVA 2MG/ML CONC/INF 5ML | 1VIAL | TBC | TEVA | 17-Apr-25 | 26-Mar-26 | No reason provided | DOXORUBICIN | As per Teva | |||
| DOZEPT 10MG FC TABS DONEPEZIL | 28TABS | 69055 | Mid- end August 2026 | ROWA | 22-Jun-26 | 08-Jul-26 | Unexpected increase in sales | DONEPEZIL | As per Rowa | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| DULOXETINE 30MG GAST RES CAPS | 28CAPS | 37031 | No return date | ACCORD HC | 16-Sep-24 | 20-May-26 | Quality issue | DULOXETINE | As per Accord | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| DULOXETINE 60MG GAST RES CAPS | 28CAPS | 37032 | No return date | ACCORD HC | 20-Mar-24 | 20-May-26 | Quality issue | DULOXETINE | As per Accord. | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| DULOXETINE CLONMEL 30MG GAST RES CAPS | 28CAPS | 37023 | TBC | CLONMEL | 26-Jan-26 | 22-May-26 | No reason provided | DULOXETINE | As per Clonmel. | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| DULOXETINE CLONMEL 60MG GAST RES CAPS | 28CAPS | 37034 | TBC | CLONMEL | 16-Dec-25 | 22-May-26 | No reason provided | DULOXETINE | As per Clonmel | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| DULOXETINE VIATRIS 30MG GAST RES CAPS | 28CAPS | 36818 | 1st April 2027 | VIATRIS | 31-Mar-26 | 20-May-26 | Quality issue | DULOXETINE | As per Viatris | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| DULOXETINE VIATRIS 60MG GAST RES CAPS | 28CAPS | 36819 | 1st April 2027 | VIATRIS | 27-Apr-26 | 20-May-26 | Quality issue | DULOXETINE | As per Viatris | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| DUROGESIC DTRANS 50MCG/HR PATCH | 5PATCH | 73219 | In Stock | JANSSEN | 30-Jun-26 | 23-Jul-26 | 23-Jul-26 | Shipping delay / distribution issue | FENTANYL | No longer on HPRA list | Not reimbursed - alternative therapeutic options available on the reimbursement list |
| DUTASTERIDE 0.5MG SOFT CAPS | 30CAPS | 54320 | TBC | TEVA | 30-Mar-26 | 20-May-26 | Unexpected increased demand | DUTASTERIDE | As per Teva | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| DUTASTERIDE KRKA 0.5MG SOFT CAPS | 30CAPS | 54302 | 20th August 2026 | KRKA PHARM | 05-Aug-26 | 11-Aug-26 | No reason provided | DUTASTERIDE | As per KRKA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| DUTASTERIDE ROWA 0.5MG SOFT CAPS | 30CAPS | 54327 | Awaiting update | ROWA | 14-May-26 | 17-Jul-26 | Increase in sales | DUTASTERIDE | As per Rowa | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| DUTASTERIDE/TAMSULO PWOOD 0.5/0.4MG CAPS | 30CAPS | 18761 | Mid August 2026 | PINEWOOD | 16-Jun-26 | 24-Jul-26 | No reason provided | DUTASTERIDE/TAMSULOSIN | As per Pinewood | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| DUTASTERIDE/TAMSULO ROWA 0.5/0.4MG CAPS | 30CAPS | 54303 | 7th September 2026 | ROWA | 04-Mar-26 | 20-Jul-26 | Unprecedented demand | DUTASTERIDE/TAMSULOSIN | As per Rowa | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| DUTASTERIDE/TAMSULOSIN HCL 0.5/0.4MG CAP | 30CAPS | 18759 | w/c 14th September 2026 | VIATRIS | 28-May-26 | 16-Jun-26 | Unexpected increased demand | DUTASTERIDE/TAMSULOSIN | As per Viatris | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| DUTASTERIDE/TAMSULOSIN HCL 0.5/0.4MG CAP | 30CAPS | 18760 | 19th August 2026 | ACCORD HC | 16-Jun-26 | 07-Aug-26 | Manufacturing delay | DUTASTERIDE/TAMSULOSIN | As per Accord | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| E45 CREAM PUMP | 500G | 4th September 2026 | KARO | 31-Jul-26 | 14-Aug-26 | No reason provided | EMOLLIENT | As per HPRA | |||
| EASOFEN 200MG FC TABS IBUPROFEN | 24TABS | End August 2026 | CLONMEL | 25-Jun-26 | 05-Aug-26 | Manufacturing delay | IBUPROFEN | As per HPRA | |||
| EASOFEN 200MG FC TABS IBUPROFEN | 48TABS | End August 2026 | CLONMEL | 24-Jul-26 | No reason provided | IBUPROFEN | As per Clonmel | ||||
| ECALTA 100MG PDR FOR CONC SOLN/INF | 1VIAL | 17th August 2026 | PFIZER | 27-Jul-26 | 11-Aug-26 | Manufacturing delay | ANIDULAFUNGIN | As per HPRA | |||
| EDRONAX 4MG TABS | 60TABS | 22861 | OOS expected 15th August. Return date 9th November 2026 | PFIZER | 04-Aug-26 | 11-Aug-26 | Manufacturing delay | REBOXETINE | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| EMBLAVEO 1.5G/0.5G PDR FOR CONC/SOLN/INF | 10VIAL | 16th August 2026 | PFIZER | 08-Jul-26 | Unexpected increased demand | AZTREONAM/AVIBACTAM | As per HPRA / Pfizer | ||||
| EMTRICITABINE/TENOFOVIR DISOPROXIL TABS | 30TABS | 77105 | Sep-26 | ACCORD HC | 22-Jul-26 | 07-Aug-26 | Manufacturing delay | EMTRICITAB/TENOFOVIR DISO | As per Accord | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| ENTECAVIR VIATRIS 0.5MG FC TABS | 30TABS | 88189 | Pending | VIATRIS | 20-Jul-26 | 27-Jul-26 | Manufacturing delay | ENTECAVIR | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| EPILIM CHRONO 200MG PRO REL TABS | 30TABS | 37038 | On Allocation | SANOFI AVE | 03-Nov-20 | 20-May-26 | VALPROATE | Not reimbursed - alternative therapeutic options available on the reimbursement list | |||
| EPILIM CHRONO 300MG PRO REL TABS | 30TABS | 37039 | On Allocation | SANOFI AVE | 03-Nov-20 | 20-May-26 | VALPROATE | Not reimbursed - alternative therapeutic options available on the reimbursement list | |||
| EPILIM CHRONOSPHERE 100MG PRO REL GRAN | 30SACH | 23503 | On Allocation | SANOFI AVE | 03-Nov-20 | 20-May-26 | VALPROATE | Not reimbursed - alternative therapeutic options available on the reimbursement list | |||
| EPILIM CHRONOSPHERE 250MG PRO REL GRAN | 30SACH | 23516 | On Allocation | SANOFI AVE | 03-Nov-20 | 20-May-26 | VALPROATE | Not reimbursed - alternative therapeutic options available on the reimbursement list | |||
| EPIPEN 300MCG SOLN FOR INJ PFP | 1PENS | 15943 | Back In Stock | VIATRIS | 17-Jul-26 | 05-Aug-26 | 05-Aug-26 | Unexpected increased demand | EPINEPHRINE | As per Viatris | Not reimbursed - alternative therapeutic options available on the reimbursement list |
| EPLERENONE VIATRIS 25MG FC TABS | 28TABS | 36897 | 17th August 2026 | VIATRIS | 22-Apr-26 | 29-Jul-26 | Unexpected increase in demand | EPLERENONE | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| EPORATIO 10000 IU/1ML SOLN FOR INJ PFS | 6SYR | 88479 | 18th September 2026 | TEVA | 19-Jul-26 | 06-Aug-26 | Manufacturing delay | EPOETIN THETA | As per Teva. | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| EPORATIO 30000 IU/1ML SOLN FOR INJ PFS | 4SYR | 88482 | OOS expected 24th August. Return date 1st December 2026 | TEVA | 10-Aug-26 | Manufacturing delay | EPOETIN THETA | As per HPRA | |||
| ERYTHROCIN 500MG TABS | 100TABS | 64076 | No confirmed resupply timeline at present, | ADVANZ | 20-Mar-26 | 08-Jul-26 | Manufacturing issue | ERYTHROMYCIN | As per Advanz | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| ERYTHROCIN LACTOBIONATE 1G PDR CONC INF | 1VIAL | 82627 | No confirmed resupply timeline. | ADVANZ | 05-Jun-26 | 04-Aug-26 | Ongoing manufacturing issue | ERYTHROMYCIN | As per Advanz. HPRA-approved BSR stock is available for hospitals. Please contact Advanz customer care team to place an order. | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| ESCITALPRO 15MG FC TABS ESCITALOPRAM | 28TABS | 13125 | Sep-26 | VIATRIS | 16-Mar-26 | 20-May-26 | Manufacturing delay | ESCITALOPRAM | As per Viatris | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| ESOMEPRAZOLE TILLO 40MG PDR SOLN/INJ/INF | 10VIAL | 1st December 2026 | AZURE | 01-May-26 | 17-Jun-26 | No reason provided | ESOMEPRAZOLE | As per HPRA | |||
| ESTRADOT 100MCG/24HRS TRANSDERMAL PATCH | 8PATCH | 47415 | Pending (on allocation when in stock) | SANDOZ | 27-Mar-26 | 27-Jul-26 | Limited stock | ESTRADIOL | As per Rowa | EMP reimbursed for duration of HPRA registered shortage | |
| ESTRADOT 37.5MCG/24HRS TRANSDERMAL PATCH | 8PATCH | 68314 | Pending | SANDOZ | 16-Apr-26 | 16-Jul-26 | No reason provided | ESTRADIOL | As per HPRA | EMP reimbursed for duration of HPRA registered shortage | |
| ESTRADOT 50MCG/24HRS TRANSDERMAL PATCH | 8PATCH | 57226 | No confirmed delivery date (on allocation when in stock) | SANDOZ | 16-Apr-26 | 16-Jul-26 | Increased demand | ESTRADIOL | As per Rowa | EMP reimbursed for duration of HPRA registered shortage | |
| ESTRADOT 75MCG/24HRS TRANSDERMAL PATCH | 8PATCH | 48323 | No confirmed delivery date | SANDOZ | 19-Feb-26 | 16-Jul-26 | Increased demand | ESTRADIOL | As per Rowa. | EMP reimbursed for duration of HPRA registered shortage | |
| ETORICOXIB 30MG FC TABS | 28TABS | 36842 | 4th January 2027 | VIATRIS | 30-Jul-26 | 05-Aug-26 | No reason provided. Short since 13th July | ETORICOXIB | As per Viatris | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| ETORICOXIB TEVA 30MG FC TABS | 28TABS | 36884 | TBC | TEVA | 24-Nov-25 | 20-May-26 | Manufacturing delay | ETORICOXIB | As per Teva | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| ETORICOXIB TEVA 60MG FC TABS | 28TABS | 36885 | 28th August 2026 | TEVA | 15-Jul-26 | 13-Aug-26 | Manufacturing delay | ETORICOXIB | As per Teva | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| ETORICOXIB TEVA 90MG FC TABS | 28TABS | 36886 | Sep-26 | TEVA | 09-Jul-26 | 14-Jul-26 | No reason provided | ETORICOXIB | As per Teva | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| EVISTA 60MG FC TABS BMODESTO | 28TABS | 67158 | Back In Stock | BMODESTO | 03-Feb-26 | 30-Jul-26 | 30-Jul-26 | Sourcing issue | RALOXIFENE | As per BModesto | Not reimbursed - alternative therapeutic options available on the reimbursement list |
| EZETIMIBE 10MG TABS | 28TABS | 36871 | 14th September 2026 | VIATRIS | 17-Jun-26 | 02-Jul-26 | Manufacturing delay | EZETIMIBE | As per Viatris | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| EZETIMIBE/SIMVASTATIN TEVA 10/40MG TABS | 30TABS | 37314 | Back In Stock (awaiting release) | TEVA | 01-May-26 | 30-Jul-26 | 30-Jul-26 | Manufacturing delay | EZETIMIBE/SIMVASTATIN | As per Teva | Not reimbursed - alternative therapeutic options available on the reimbursement list |
| EZETROL 10MG TABS IMED | 30TABS | 67078 | No return date | IMED | 20-Jan-26 | 20-May-26 | Europe wide shortage | EZETIMIBE | As per IMED | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| EZETROL 10MG TABS PCO | 28TABS | 23275 | Ongoing intermittent supply. | PCO | 20-Jan-26 | 15-Jul-26 | No reason provided | EZETIMIBE | As per PCO | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| FASLODEX 250MGSOLN FOR INJ PFS PCO | 2SYR | 88793 | No return to stock date | PCO | 20-Apr-26 | 08-Jul-26 | Unable to source stock at a workable price | FULVESTRANT | As per PCO | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| FASTURTEC 1.5MG/ML PDR+SOLV/SOL/INF 1ML | 3VIAL | TBC | SANOFI AVE | 05-May-26 | 07-Jul-26 | No reason provided | RASBURICASE | As per Sanofi. | |||
| FE CARBOXYMALT 50MG/ML DISP/INJ/INF 20ML | 1VIAL | Return date TBC | ROWEX | 17-Jul-26 | 27-Jul-26 | Delayed delivery | FERRIC CARBOXYMALTOSE | As per Rowa | |||
| FENTANYL 50MCG/ML SOL FOR INJ 10ML | 10AMP | Back In Stock | CARAGEN | 04-Jun-26 | 27-Jul-26 | 27-Jul-26 | Relaunched 30.06.26 | FENTANYL | As per Caragen | ||
| FESOTERODINE ACCORD 8MG PRO REL TABS | 28TABS | 66940 | TBC | ACCORD HC | 05-Feb-26 | 20-May-26 | Manufacturing delay | FESOTERODINE | As per Accord | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| FESOTERODINE CLONMEL 4MG PRO REL TABS | 30TABS | 66934 | Back In Stock | CLONMEL | 07-Jul-26 | 05-Aug-26 | 05-Aug-26 | No reason provided | FESOTERODINE | As per Clonmel | Not reimbursed - alternative therapeutic options available on the reimbursement list |
| FEXOFENADINE HYDROCHLORIDE 180MG FC TABS | 30TABS | 48210 | In Stock | AZURE | 29-Jun-26 | 24-Jul-26 | 24-Jul-26 | Shipping delay | FEXOFENADINE | No longer on HPRA list | Not reimbursed - alternative therapeutic options available on the reimbursement list |
| FINGOLIMOD ACCORD 0.5MG HARD CAPS | 28CAPS | 89223 | Discontinued (Apr 26) | ACCORD HC | 17-Feb-25 | 27-Jul-26 | 27-Jul-26 | Manufacturing delay | As per Accord | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| FINGOLIMOD CLONMEL 0.5MG HARD CAPS | 28CAPS | 89398 | Mid September 2026 | CLONMEL | 19-Dec-25 | 10-Jun-26 | Manufacturing delay | FINGOLIMOD | As per Clonmel | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| FLECAINIDE 100MG TABS | 60TABS | 26080 | Nov-26 | TEVA | 05-Sep-25 | 23-Jul-26 | Manufacturing delay | FLECAINIDE | As per Teva. | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| FLECAINIDE 50MG TABS | 60TABS | 26072 | Nov-26 | TEVA | 06-May-25 | 21-May-26 | Manufacturing delay | FLECAINIDE | As per Teva | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| FLUCILLIN 250MG CAPS FLUCLOXACILLIN | 100CAPS | 25194 | Mid-September 2026 | PINEWOOD | 08-Oct-25 | 24-Jul-26 | Manufacturing delay | FLUCLOXACILLIN | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| FLUCILLIN 250MG CAPS FLUCLOXACILLIN | 500CAPS | 24821 | Unable to provide date | PINEWOOD | 08-Oct-25 | 24-Jul-26 | Manufacturing delay | FLUCLOXACILLIN | As per Pinewood | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| FOLIC ACID 5MG TABS | 56TABS | 25805 | 30th November 2026 | CLONMEL | 07-Jul-26 | 06-Aug-26 | No reason provided | FOLIC ACID | As per HPRA | EMP reimbursed for duration of HPRA registered shortage | |
| FOLINIC ACID 10MG/ML SOLN/ INJ/INF 5ML | 1VIAL | Back In Stock | CARAGEN | 05-Dec-25 | 27-Jul-26 | 27-Jul-26 | Relaunched May 26 | FOLINIC ACID | As per Caragen | ||
| FOLINIC ACID 10MG/ML SOLN/INJ/INF 50ML | 1VIAL | Awaiting update | CARAGEN | 05-Dec-25 | 27-Jul-26 | No reason provided | FOLINIC ACID | As per Caragen | |||
| FUCITHALMIC 10MG/G VISCOUS EYE DROP SUSP | 5G | 26441 | No confirmed timeline | ADVANZ | 13-Sep-19 | 10-Aug-26 | Long term manufacturing issue | FUSIDIC ACID | Contact Advanz Customer Service 1890 252 474 for further info. HPRA shows 31.10.26 return date | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| FUROSEMIDE 40MG TABS | 500TABS | 74551 | TBC | CLONMEL | 22-May-26 | 07-Jul-26 | No reason provided | FUROSEMIDE | As per Clonmel | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| GABAPENTIN ROSEMONT 50MG/ML ORAL SOLN | 150ML | 36252 | 31st August 2026 | ROSEMONT | 10-Aug-26 | Quality issue | GABAPENTIN | As per HPRA | |||
| GABIN 100MG HARD CAPS GABAPENTIN | 100CAPS | 76704 | End August / early September 2026 | ROWA | 10-Jul-26 | 13-Aug-26 | Manufacturing delay | GABAPENTIN | As per Rowa | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| GABIN 300MG CAPS GABAPENTIN | 100CAPS | 76720 | TBC | ROWA | 30-Jul-26 | 05-Aug-26 | Manufacturing delay | GABAPENTIN | As per Rowa | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| GABIN 400MG CAPS GABAPENTIN | 100CAPS | 76732 | End August / early September 2026 | ROWA | 26-Jun-26 | 13-Aug-26 | Delivery delay | GABAPENTIN | As per Rowa | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| GADOVIST 1.0MMOL/ML SOLN/INJ 10ML PFS | 1SYR | 20th August 2026 | BAYER | 28-Jul-26 | 10-Aug-26 | Quality issue | GADOBUTROL | As per HPRA | |||
| GADOVIST 1.0MMOL/ML SOLN/INJ 10ML PFS | 1SYR | In Stock | BAYER | 15-Jun-26 | 23-Jul-26 | 23-Jul-26 | Unexpected increased demand | GADOBUTROL | No longer on HPRA list | ||
| GAMANIL 70MG TABS | 56TABS | 25143 | Aug-27 | ZENTIVA | 18-Dec-23 | 20-May-26 | Very complex product transfer resulting in a number of delays. | LOFEPRAMINE | As per Zentiva | EMP reimbursed for duration of HPRA registered shortage | |
| GASTROGRAFIN ORAL AND RECTAL SOLUTION | 100ML | Pending | BAYER | 10-Mar-26 | 11-Aug-26 | Quality issue | SOD AMIDOTRI/MEGLUM AMIDO | As per HPRA | |||
| GAVISCON PEPPERMINT CHEWABLE TABS | 24TABS | 28th September 2026 | RECKITTS | 29-Jul-26 | 11-Aug-26 | No reason provided | SOD ALG/SOD H CARB/CACARB | As per HPRA | |||
| GEODON 80MG HARD CAPS | 60CAPS | 36018 | 30th September 2026 | VIATRIS | 07-May-26 | 16-Jun-26 | Manufacturing delay | ZIPRASIDONE | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| GEROQUEL 100MG FC TABS QUETIAPINE | 60TABS | 46081 | Back In Stock | VIATRIS | 16-Feb-26 | 31-Jul-26 | 30-Jul-26 | Unexpected increased demand | QUETIAPINE | As per Viatris | EMP reimbursed for duration of HPRA registered shortage |
| GEROQUEL 25MG FC TABS QUETIAPINE | 60TABS | 46080 | Pending | VIATRIS | 17-Feb-26 | 12-Aug-26 | Unexpected increased demand | QUETIAPINE | As per HPRA | EMP reimbursed for duration of HPRA registered shortage | |
| GLYCEROL SUPPOSITORIES BP FOR ADULTS | 12SUPPOS | In Stock | FANNIN | 20-Jul-26 | 29-Jul-26 | 29-Jul-26 | Manufacturing delay | GLYCEROL | No longer on HPRA list | ||
| GOLDEN EYE 0.15% OINTMENT | 5G | Jan-27 | CAM HC SUP | 29-Aug-25 | 06-Oct-25 | Manufacturing delays | DIBROMPROPAMIDINE | As per HPRA | |||
| GREPID 75MG FC TABS CLOPIDOGREL | 28TABS | 27519 | Mid-September 2026 | PHARMATHEN | 20-Mar-25 | 24-Jul-26 | Shipping delay / distribution issue | CLOPIDOGREL | As per Pinewood | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| HYCAMTIN 0.25MG CAPS | 10CAPS | 88560 | TBC | SANDOZ | 17-Jul-26 | 27-Jul-26 | Quality issue | TOPOTECAN | As per Rowa | Not reimbursed - alternative strengths available on the reimbursement list | |
| HYPNOVEL 10MG/5ML SOLN FOR INJ | 10AMP | 28648 | Back In Stock | ATHENA | 03-Jun-26 | 14-Aug-26 | 14-Aug-26 | Manufacturing delay | MIDAZOLAM | As per Athena | EMP reimbursed for duration of HPRA registered shortage |
| HYTRIN 10MG TABS | 28TABS | 27707 | Discontinued | ADVANZ | 05-Jun-26 | 04-Aug-26 | 31-Jul-26 | No reason provided | TERAZOSIN | As per Advanz | Not reimbursed - alternative therapeutic options available on the reimbursement list |
| HYTRIN 2MG TABS | 28TABS | 27650 | Discontinued | ADVANZ | 10-Mar-23 | 04-Aug-26 | 31-Jul-26 | Delivery delay | TERAZOSIN | As per Advanz. | Not reimbursed - alternative therapeutic options available on the reimbursement list |
| IBANDRONIC ACID MYLAN 150MG FC TABS | 1TABS | 14041 | No back in stock date available at the moment | VIATRIS | 03-Sep-25 | 20-May-26 | Unexpected increased demand | IBANDRONIC ACID | As per Viatris | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| IBANDRONIC ACID TEVA 150MG FC TABS | 1TABS | 16130 | TBC | TEVA | 07-Dec-23 | 20-May-26 | No reason provided | IBANDRONIC ACID | As per Teva (HPRA shows 01.12.26 return date) | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| IBUPROFEN 200MG FC TABS | 100TABS | 67172 | Awaiting return date | ACCORD HC | 16-Apr-26 | 20-May-26 | Manufacturing delay | IBUPROFEN | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| IMATINIB TEVA 100MG FC TABS | 60TABS | 88675 | Aug-26 | TEVA | 25-Jun-26 | 07-Aug-26 | No reason provided | IMATINIB | As per Teva. HPRA shows 26.08.26 return date | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| IMDUR 60MG PRO REL TABS | 28TABS | 31410 | Pending | NAVAMEDIC | 29-Sep-23 | 30-Jul-26 | Unexpected increase in demand | ISOSORBIDE MONONITRATE | As per HPRA 30.07.26 Navamedic advised they have no estimate of re-supply date for Imdur in Ireland | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| IMUGER 25MG FC TABS AZATHIOPRINE | 100TABS | 59303 | OOS expected 17th August. Return date 2nd November 2026 | VIATRIS | 31-Jul-26 | 11-Aug-26 | Unexpected increased demand | AZATHIOPRINE | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| IMULDOSA 130MG CONC FOR SOLN INF 26ML | 1VIAL | No return date | ACCORD HC | 16-Jun-26 | 30-Jul-26 | Unexpected increased demand | USTEKINUMAB | As per Accord | |||
| INDORAMIN 20MG FC TABS | 60TABS | 76003 | Early August 2026 | CHEMIDEX | 20-Jan-26 | 24-Jul-26 | Manufacturing delay | INDORAMIN | As per Allphar. | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| INNOVACE 2.5MG TABS | 28TABS | 29722 | 24th September 2026 | ORGANON | 10-Jul-26 | 27-Jul-26 | Manufacturing delay | ENALAPRIL | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| INNOVACE 5MG TABS | 28TABS | 29696 | 8th October 2026 | ORGANON | 16-Jun-26 | 02-Jul-26 | Manufacturing delay | ENALAPRIL | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| INSUL LEVEMIR FLEXPEN 100 UNITS/ML BMODE | 5PENS | 67213 | Awaiting update | BMODESTO | 12-Mar-26 | 08-Jul-26 | Company trying to source supply | INSULIN DETEMIR | As per BModesto | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| INSUL LEVEMIR PENFILL100 UNIT/ML CTG PCO | 5CARTRIDG | 63005 | Limited stock due (as at 15.07.26) | PCO | 23-Jan-26 | 15-Jul-26 | PCO have had no supply for several months | INSULIN DETEMIR | As per PCO | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| INSUL NOVORAPID PENFILL 100 U/ML CTG | 5CARTRIDG | 63121 | On Allocation | NOVO NRDSK | 06-Mar-20 | 08-Jul-26 | INSULIN ASPART | Not reimbursed - alternative therapeutic options available on the reimbursement list | |||
| IPRATROPIUM STERI-NEB 250MCG/ML NEB SOLN | 20NEB | 45080 | Back In Stock | TEVA | 01-Aug-24 | 06-Aug-26 | 05-Aug-26 | Manufacturing delay | IPRATROPIUM | As per Teva | |
| IRINOTECAN 20MG/ML CONC/SOL/INF 25ML POA | 1VIAL | In Stock | ACCORD HC | 15-Jul-26 | 05-Aug-26 | 05-Aug-26 | No reason provided | IRINOTECAN | No longer on HPRA list | ||
| IRUXOL MONO 1.2 U/G OINTMENT | 20G | 29297 | Pending | S&NEPHEW | 31-Mar-26 | 20-May-26 | Manufacturing delay | COLLAGENASE | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| IVABRADINE KRKA 5MG FC TABS | 56TABS | 42790 | Back In Stock | KRKA PHARM | 23-Mar-26 | 27-Jul-26 | 24-Jul-26 | No reason provided | IVABRADINE | As per KRKA | Not reimbursed - alternative therapeutic options available on the reimbursement list |
| IVABRADINE ROWEX 5MG FC TABS | 56TABS | 42795 | Early 2027 | ROWA | 30-Jul-26 | 05-Aug-26 | Manufacturing dealy | IVABRADINE | As per Rowa | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| IVABRADINE ROWEX 7.5MG FC TABS | 56TABS | 42796 | TBC | ROWA | 30-Jul-26 | 05-Aug-26 | Manufacturing delay | IVABRADINE | As per Rowa | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| JEXT 300MCG SOLN FOR INJ PFP | 1PENS | 39107 | In Stock | ALK ABELLO | 19-Jun-26 | 23-Jul-26 | 23-Jul-26 | Unexpected increased demand | EPINEPHRINE | No longer on HPRA list | Not reimbursed - alternative therapeutic options available on the reimbursement list |
| KALCIPOS D FORTE 500MG/800IU CHEW TABS | 30TABS | 34005 | Pending | COOPER CH | 11-Jun-26 | 18-Jun-26 | Manufacturing delay | CA CARBONATE/COLECALCIFER | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| KALCIPOS D FORTE 500MG/800IU CHEW TABS | 60TABS | 34006 | Pending | COOPER CH | 11-Jun-26 | 18-Jun-26 | Manufacturing delay | CA CARBONATE/COLECALCIFER | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| KALCIPOS D FORTE 500MG/800IU FC TABS | 30TABS | 17534 | Pending | COOPER CH | 11-Jun-26 | 18-Jun-26 | Manufacturing delay | CA CARBONATE/COLECALCIFER | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| KALCIPOS D FORTE 500MG/800IU FC TABS | 60TABS | 17565 | Pending | COOPER CH | 11-Jun-26 | 18-Jun-26 | Manufacturing delay | CA CARBONATE/COLECALCIFER | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| KAY-CEE-L 7.5% SYRUP | 500ML | 29769 | Awaiting update | SYRI PHARM | 04-Mar-24 | 20-May-26 | Currently under testing and regulatory approval | POTASSIUM CHLORIDE | As per Syri Pharma | EMP reimbursed for duration of HPRA registered shortage | |
| KOPEN 250MG TABS | 100TABS | 38512 | 24th August 2026 | ATHLONE PH | 28-Jul-26 | 05-Aug-26 | Manufacturing delay | PHENOXYMETHYLPENICILLIN | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| LAMISIL 1% CREAM | 30G | 30973 | 2nd October 2026 | KARO | 31-Jul-26 | 14-Aug-26 | No reason provided | TERBINAFINE | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| LAMISIL ONCE 1% CUTANEOUS SOLN | 4G | 28th August 2026 | KARO | 31-Jul-26 | No reason provided | TERBINAFINE | As per HPRA | ||||
| LARIG 100MG DISP TABS LAMOTRIGINE | 56TABS | 30664 | BaCK iN sTOCK | ROWA | 14-May-26 | 17-Jul-26 | 17-Jul-26 | Delayed delivery | LAMOTRIGINE | As per Rowa | Not reimbursed - alternative therapeutic options available on the reimbursement list |
| LECALPIN 20MG FC TABS LERCANIDIPINE | 28TABS | 26005 | 14th August 2026 | ACCORD HC | 22-Jul-26 | 07-Aug-26 | Unexpected increased demand | LERCANIDIPINE | As per Accord | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| LENALIDOMIDE ROWEX 15MG HARD CAPS | 21CAPS | 89148 | Back In Stock | ROWA | 05-Jun-26 | 27-Jul-26 | 27-Jul-26 | Manufacturing delay | LENALIDOMIDE | As per Rowa | Not reimbursed - alternative therapeutic options available on the reimbursement list |
| LENALIDOMIDE ROWEX 25MG HARD CAPS | 21CAPS | 89149 | Back In Stock | ROWA | 24-Apr-26 | 13-Aug-26 | 13-Aug-26 | Delayed delivery | LENALIDOMIDE | As per Rowa | Not reimbursed - alternative therapeutic options available on the reimbursement list |
| LENZETTO 1.53MG/SPRAY TRANSDERMAL SPRAY | 1SPY | 78085 | OOS expected 17th August. Return date 22nd October 2026 | GEDEON RCH | 03-Aug-26 | 11-Aug-26 | Unexpected increased demand | ESTRADIOL HEMIHYDRATE | As per HPRA. On allocation when in stock. Due to demand allocated stock is used within 2 weeks. Increased volumes expected October 2026 | EMP reimbursed for duration of HPRA registered shortage | |
| LERCANIDIPINE CLONMEL 10MG FC TABS | 28TABS | 41032 | Early September 2026 | CLONMEL | 25-Jun-26 | 24-Jul-26 | Manufacturing delay | LERCANIDIPINE | As per Clonmel | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| LERCANIDIPINE CLONMEL 20MG FC TABS | 28TABS | 41665 | Mid September 2026 | CLONMEL | 25-Jun-26 | 08-Jul-26 | Manufacturing delay | LERCANIDIPINE | As per Clonmel | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| LETROZOLE 2.5MG FC TABS | 28TABS | 24520 | Sep-26 | ACCORD HC | 05-Feb-26 | 07-Aug-26 | Unexpected increased demand | LETROZOLE | As per Accord. | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| LETROZOLE TEVA 2.5MG FC TABS | 30TABS | 24517 | Sep-26 | TEVA | 22-Apr-26 | 20-May-26 | Manufacturing delay | LETROZOLE | As per Teva | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| LEVETIRACETAM CLONMEL 1000MG FC TABS | 60TABS | 51419 | Back In Stock | CLONMEL | 15-Jul-25 | 24-Jul-26 | 24-Jul-26 | No reason provided | LEVETIRACETAM | As per Clonmel | Not reimbursed - alternative therapeutic options available on the reimbursement list |
| LEVOTHYROXINE TEVA 100MCG TABS | 28TABS | 34533 | Aug-26 | TEVA | 27-Feb-26 | 05-Aug-26 | Manufacturing delay | LEVOTHYROXINE | As per Teva. HPRA shows 14.09.26 return date | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| LEVOTHYROXINE TEVA 50MCG TABS | 28TABS | 34532 | Back In Stock (awaiting release) | TEVA | 08-May-26 | 23-Jul-26 | 23-Jul-26 | Manufacturing delay | LEVOTHYROXINE | As per Teva | Not reimbursed - alternative therapeutic options available on the reimbursement list |
| LIBRIUM 10MG HARD CAPS | 100CAPS | 31550 | 16th August 2026 | VIATRIS | 17-Feb-26 | 29-Jul-26 | API Shortage / unavailability | CHLORDIAZEPOXIDE | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| LIBRIUM 5MG HARD CAPS | 100CAPS | 72099 | 16th August 2026 | VIATRIS | 13-Apr-26 | 29-Jul-26 | API Shortage / unavailability | CHLORDIAZEPOXIDE | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| LISPRIL-HCTZ 20MG/12.5MG TABS | 30TABS | 31857 | Back In Stock | ROWA | 05-Jun-26 | 17-Jul-26 | 17-Jul-26 | Delayed delivery | LISINOPRIL/HCTZ | As per Rowa | Not reimbursed - alternative therapeutic options available on the reimbursement list |
| LONQUEX 6MG/0.6ML SOLN FOR INJ | 1VIAL | 89416 | Nov-26 | TEVA | 04-Jun-26 | 06-Aug-26 | No reason provided | LIPEGFILGRASTIM | As per Teva | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| LOXENTIA 20MG GR CAPS DULOXETINE | 28CAPS | 36872 | 31st August 2026 | KRKA PHARM | 23-Jun-26 | 08-Jul-26 | No reason provided | DULOXETINE | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| LYCLEAR 5% DERMAL CREAM | 30G | 32292 | On Allocation | GSK MED | 03-May-24 | 20-May-26 | Supply constrained due to increased demand | PERMETHRIN | As per GSK | EMP reimbursed for duration of HPRA registered shortage | |
| LYRICA 25MG HARD CAPS | 84CAPS | 32236 | 17th August 2026 | VIATRIS | 04-Aug-26 | 11-Aug-26 | Manufacturing delay | PREGABALIN | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| LYRICA 50MG HARD CAPS | 84CAPS | 32241 | 17th September 2026 | VIATRIS | 17-Jun-26 | 26-Jun-26 | Manufacturing delay | PREGABALIN | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| MEFAC 500MG FC TABS MEFENAMIC ACID | 100TABS | 32999 | Pending | ROWA | 08-Jun-26 | 16-Jun-26 | Unexpected increased demand | MEFENAMIC ACID | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| MEGACE 160MG TABS | 30TABS | 33472 | 15th September 2026 | BAUSCH HEA | 18-Mar-26 | 14-Jul-26 | Manufacturing delay | MEGESTROL | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| MEKTOVI 45MG FC TABS | 28TABS | 89417 | In Stock | PIERRE FAB | 16-Jun-26 | 07-Aug-26 | 07-Aug-26 | Unexpected increased demand | BINIMETINIB | No longer on HPRA list | Not reimbursed - alternative strength available on the reimbursement list |
| MELFEN 200MG FC TABS IBUPROFEN | 100TABS | 77348 | 21st August 2026 | CLONMEL | 27-Jul-26 | 05-Aug-26 | Manufacturing delay | IBUPROFEN | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| MENTHOLATUM DEEP HEAT SPRY CUT SPRAY SOL | 150ML | 30th June 2027 | MENTHOLATM | 08-Jan-25 | 16-Jun-26 | Manufacturing delay | As per HPRA | ||||
| MEROPENEM AUROBINDO 1G PDR/SOLN/INJ/INF | 10VIAL | Pending | ATHLONE PH | 15-Jan-26 | 04-Mar-26 | Quality issue | MEROPENEM | As per HPRA. | |||
| METHADONE MIXTURE DTF SF 1MG/ML ORAL SOL | 500ML | 9110 | 31st August 2026 | MARTINDALE | 22-Jul-26 | 11-Aug-26 | Manufacturing delay | METHADONE | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| METOCOR 50MG TABS METOPROLOL | 100TABS | 61525 | 20th August 2026 | ROWA | 30-Jul-26 | 13-Aug-26 | Delivery delay | METOPROLOL | As per Rowa | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| MIDON 2.5MG TABS | 100TABS | 34444 | 30th November 2026 | ATHENA | 19-May-26 | 10-Jun-26 | Unexpected increased demand | MIDODRINE | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| MINIMS OXYBUPROCAINE HCL 0.4% EYE DROPS | 20UDV | 34002 | Back In Stock | BAUSCH&L | 30-Jun-26 | 04-Aug-26 | 31-Jul-26 | Increased sales | OXYBUPROCAINE | As per Uniphar | |
| MIRAP DISTAB 15MG ORODISP TABS MIRTAZAPI | 30TABS | 33549 | Mid September 2026 | ROWA | 08-May-26 | 13-Aug-26 | Awaiting confirmation of next delivery Artwork needs to be finalised | MIRTAZAPINE | As per Rowa | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| MIVACRON 2MG/ML SOLN FOR INJ 5ML | 5AMP | 8th September 2026 | ASPEN | 05-Jan-26 | Manufacturing delay | MIVACURIUM | As per HPRA | ||||
| MONTELUKAST PAEDIATRIC 4MG CHEWABLE TABS | 28TABS | 45130 | TBC | ACCORD HC | 16-Sep-24 | 20-May-26 | Ongoing QA issue | MONTELUKAST | As per Accord | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| MONTELUKAST PAEDIATRIC 5MG CHEWABLE TABS | 28TABS | 45131 | TBC | ACCORD HC | 12-Mar-26 | 20-May-26 | Manufacturing delay | MONTELUKAST | As per Accord | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| MONTELUKAST VIATRIS 5MG CHEWABLE TABS | 28TABS | 45116 | No return date at present | VIATRIS | 17-Jun-26 | 06-Jul-26 | Manufacturing delay | MONTELUKAST | As per Viatris | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| MORPHINE SULPHATE 10MG/ML SOLN/INJ 1ML | 10AMP | Aug-26 | CARAGEN | 29-May-25 | 27-Jul-26 | No reason provided | MORPHINE SULFATE | As per Caragen | |||
| MORPHINE SULPHATE 30MG/ML SOLN/INJ 1ML | 10AMP | Aug-26 | CARAGEN | 29-May-25 | 27-Jul-26 | No reason provided | MORPHINE SULFATE | As per Caragen | |||
| MOVICOL 13.8G POWDER ORAL SOLN SACHET | 20SACH | 34521 | Pending | NORGINE | 20-Jul-26 | 27-Jul-26 | Quality issue | MACROGOL 3350 | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| MOVICOL 13.8G POWDER ORAL SOLN SACHET | 30SACH | 34514 | Pending | NORGINE | 20-Jul-26 | 27-Jul-26 | Quality issue | MACROGOL 3350 | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| MOVICOL PAED PLAIN 6.9G PDR OR SOLN SACH | 30SACH | 34528 | 30th September 2026 | NORGINE | 03-Jul-26 | 14-Jul-26 | Quality issue | MACROGOL 3350 | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| MOVIPREP POWDER FOR ORAL SOLUTION | 4SACH | 30th September 2026 | NORGINE | 30-Jul-26 | 13-Aug-26 | Quality issue | MACROGOL 3350 | As per HPRA | |||
| MYCOBUTIN 150MG CAPS | 30CAPS | 64723 | Mid September 2026 | PFIZER | 27-Apr-26 | 08-Jul-26 | API shortage / unavailability | RIFABUTIN | As per Pfizer | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| MYCOPHENOLATE MOFETIL 500MG FC TABS | 50TABS | 88322 | Back In Stock | ACCORD HC | 26-Jun-26 | 30-Jul-26 | 30-Jul-26 | Shipping delay / distribution issue | MYCOPHENOLATE | As per Accord | Not reimbursed - alternative therapeutic options available on the reimbursement list |
| MYCOPHENOLATE MOFETIL ACCORD 250MG CAPS | 100CAPS | 88858 | Pending | ACCORD HC | 17-Jun-26 | 09-Jul-26 | Shipping delay / distribution issue | MYCOPHENOLATE | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| NALTREXONE HYDROCHLORIDE 50MG FC TABS | 28TABS | 15085 | Sep-26 | ACCORD HC | 19-Feb-26 | 22-Jun-26 | Manufacturing delay | NALTREXONE | As per Accord | EMP reimbursed for duration of HPRA registered shortage | |
| NAPROXEN 250MG GAST RES TABS | 56TABS | 35808 | Back In Stock (awaiting release) | AZURE | 04-Jun-26 | 30-Jul-26 | 30-Jul-26 | Shipping delay | NAPROXEN | As per Azure | Not reimbursed - alternative therapeutic options available on the reimbursement list |
| NAPROXEN 500MG GAST RES TABS | 56TABS | 35809 | Back In Stock (awaiting release) | AZURE | 04-Jun-26 | 30-Jul-26 | 30-Jul-26 | Shipping delay | NAPROXEN | As per Azure | Not reimbursed - alternative therapeutic options available on the reimbursement list |
| NAUDICELLE PLUS CAPS | 336CAPS | 35483 | October 2026 (tentative) | BIO OIL | 30-Jun-26 | 14-Jul-26 | Manufacturing issue | EVENING PRIM/MARINE/TOCOP | As per Uniphar | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| NEURONTIN 100MG HARD CAPS | 100CAPS | 36269 | 9th November 2026 | VIATRIS | 17-Jul-26 | 31-Jul-26 | Unexpected increased demand. | GABAPENTIN | As per Viatris | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| NEUROSTIL 300MG HARD CAPS GABAPENTIN | 100CAPS | 36783 | Back In Stock | TEVA | 19-May-26 | 13-Aug-26 | 13-Aug-26 | Manufacturing delay | GABAPENTIN | As per Teva | Not reimbursed - alternative therapeutic options available on the reimbursement list |
| NEUROSTIL 400MG CAPS HARD GABAPENTIN | 100CAPS | 36794 | Oct-26 | TEVA | 25-Nov-25 | 06-Aug-26 | Manufacturing delay | GABAPENTIN | As per Teva | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| NIMBEX 2MG/ML SOLN FOR INJ/INF 2.5ML | 5AMP | Return date pending | ASPEN | 27-Apr-26 | 01-May-26 | Quality issue | CISATRACURIUM | As per HPRA | |||
| NIQUITIN MINI 2MG MINT LOZENGES | 100LOZ | 66866 | Back In Stock | PERRIGO | 13-Feb-26 | 31-Jul-26 | 30-Jul-26 | Shipping delay / distribution issue | NICOTINE | As per Chefaro | Not reimbursed - alternative therapeutic options available on the reimbursement list |
| NOQTURINA 50MCG ORAL LYOPHILISATE | 30TABS | 36969 | In Stock | FERRING | 21-Jul-26 | 05-Aug-26 | 05-Aug-26 | Unexpected increased demand | DESMOPRESSIN | No longer on HPRA list | Not reimbursed - alternative therapeutic options available on the reimbursement list |
| NORADRENALINE 1:1000 CONC/SOLN/INF 2ML | 5AMP | 9th November 2026 | PFIZER | 21-Apr-26 | 07-Aug-26 | Manufacturing delay | NOREPINEPHRINE | As per HPRA | |||
| NOTIABOLFEN XL 150MG PRO REL TABS | 60TABS | 31787 | Oct-26 | ACCORD HC | 04-Feb-26 | 07-Aug-26 | Manufacturing delay | QUETIAPINE | As per Accord | EMP reimbursed for duration of HPRA registered shortage | |
| NOTIABOLFEN XL 200MG PRO REL TABS | 60TABS | 32632 | TBC | ACCORD HC | 21-Jul-25 | 20-May-26 | Manufacturing delay | QUETIAPINE | As per Accord. | EMP reimbursed for duration of HPRA registered shortage | |
| NOTIABOLFEN XL 300MG PRO REL TABS | 60TABS | 32743 | TBC | ACCORD HC | 21-Jul-25 | 20-May-26 | Manufacturing delay | QUETIAPINE | As per Accord. | EMP reimbursed for duration of HPRA registered shortage | |
| NOTIABOLFEN XL 400MG PRO REL TABS | 60TABS | 32796 | TBC | ACCORD HC | 21-Jul-25 | 20-May-26 | Manufacturing delay | QUETIAPINE | As per Accord. | EMP reimbursed for duration of HPRA registered shortage | |
| NOTIABOLFEN XL 50MG PRO REL TABS | 60TABS | 32604 | Back In Stock | ACCORD HC | 05-Aug-25 | 07-Aug-26 | 07-Aug-26 | Manufacturer delay | QUETIAPINE | As per Accord | EMP reimbursed for duration of HPRA registered shortage |
| NUROFEN FOR CHILDREN 6+ ORANGE 200MG/5ML | 100ML | In Stock | RECKITTS | 04-Jun-26 | 27-Jul-26 | 24-Jul-26 | Manufacturing delay | IBUPROFEN | No longer on HPRA list | ||
| OLANZAPINE 10MG FC TABS | 28TABS | 32926 | Back In Stock | CLONMEL | 22-May-26 | 05-Aug-26 | 05-Aug-26 | No reason provided | OLANZAPINE | As per Clonmel | Not reimbursed - alternative therapeutic options available on the reimbursement list |
| OLANZAPINE 15MG FC TABS | 28TABS | 32927 | Back In Stock | CLONMEL | 03-Jun-26 | 05-Aug-26 | 05-Aug-26 | Manufacturing delay | OLANZAPINE | As per Clonmel | Not reimbursed - alternative therapeutic options available on the reimbursement list |
| OLANZAPINE 2.5MG FC TABS | 28TABS | 32923 | Back In Stock | CLONMEL | 10-Feb-26 | 05-Aug-26 | 05-Aug-26 | No reason provided | OLANZAPINE | As per Clonmel | Not reimbursed - alternative therapeutic options available on the reimbursement list |
| OLANZAPINE 7.5MG FC TABS | 56TABS | 32925 | Early November 2026 | CLONMEL | 03-Jun-26 | 12-Aug-26 | Manufacturing delay | OLANZAPINE | As per Clonmel. HPRA shows 28.10.26 return date | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| OLANZAPINE VIATRIS 10MG FC TABS | 28TABS | 32953 | 30th April 2027 | VIATRIS | 16-Jun-26 | 11-Aug-26 | Manufacturing delay | OLANZAPINE | As per Viatris | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| OLANZAPINE VIATRIS 5MG FC TABS | 28TABS | 32951 | 1st March 2027 | VIATRIS | 08-May-26 | 22-May-26 | Manufacturing delay | OLANZAPINE | As per Viatris | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| OLMESARTAN MEDOXOMIL 10MG FC TABS | 28TABS | 37623 | Oct-26 | ACCORD HC | 22-Jul-25 | 07-Aug-26 | Unexpected increased demand | OLMESARTAN | As per Accord. | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| ONDANSETRON 4MG FC TABS | 30TABS | 55360 | Back In Stock (awaiting release) | TEVA | 26-Mar-26 | 23-Jul-26 | 23-Jul-26 | Manufacturing delay | ONDANSETRON | As per Teva | Not reimbursed - alternative therapeutic options available on the reimbursement list |
| ONDANSETRON 8MG FC TABS | 10TABS | 55361 | Sep-26 | TEVA | 11-Nov-25 | 02-Jul-26 | Manufacturing delay | ONDANSETRON | As per Teva | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| OXALIPLATIN 5MG/ML CONC/SOLN/INF 10ML | 1VIAL | TBC | ACCORD HC | 13-Mar-26 | 27-Mar-26 | Manufacturing delay | OXALIPLATIN | As per Accord | |||
| OXYBUTYNIN HYDROCHLORIDE 5MG TABS | 84TABS | 32334 | No Return Date | ACCORD HC | 26-Jun-25 | 07-Aug-26 | Manufacturing delay | OXYBUTYNIN | As per Accord | EMP reimbursed for duration of HPRA registered shortage | |
| OXYCONTIN 5MG PRO REL TABS | 28TABS | 59182 | 31st August 2026 | MUNDIPHARM | 13-Jul-26 | 14-Aug-26 | Manufacturing delay | OXYCODONE | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| OXYNORM 10MG/ML SOLN FOR INJ 1ML | 5AMP | 59017 | In Stock | MUNDIPHARM | 13-Jul-26 | 31-Jul-26 | 31-Jul-26 | Shipping delay / distribution issue | OXYCODONE | No longer on HPRA list | Not reimbursed - alternative therapeutic options available on the reimbursement list |
| OZALIN 2MG/ML ORAL SOLN SINGLE DOSE 5ML | 10AMP | 31st December 2027 | NORDICPHAR | 07-Apr-26 | Regulatory issue | MIDAZOLAM | As per HPRA | ||||
| PABRINEX IV HIGH POTENCY CONC/SOLN/INF | 12AMP | Pending | GRUNENTHAL | 07-May-24 | 22-Jul-26 | Manufacturing issues | VITAMIN B/VITAMIN C | As per HPRA | |||
| PALMEUX 100MG PRO REL SUSP FOR INJ PFS | 1SYR | 67003 | No confirmed timeline at the moment. | ADVANZ | 12-Dec-25 | 20-May-26 | Quality issue | PALIPERIDONE | As per Advanz. HPRA shows March 2027 return date | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| PALMEUX 150MG PRO REL SUSP FOR INJ PFS | 1SYR | 67004 | No confirmed timeline at the moment. | ADVANZ | 12-Dec-25 | 20-May-26 | Quality issue | PALIPERIDONE | As per Advanz. HPRA shows March 2027 return date | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| PALMEUX 50MG PRO REL SUSP FOR INJ PFS | 1SYR | 67001 | No confirmed timeline at the moment. | ADVANZ | 12-Dec-25 | 20-May-26 | Quality issue | PALIPERIDONE | As per Advanz. HPRA shows March 2027 return date | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| PALMEUX 75MG PRO REL SUSP FOR INJ PFS | 1SYR | 67002 | No confirmed timeline at the moment. | ADVANZ | 12-Dec-25 | 20-May-26 | Quality issue | PALIPERIDONE | As per Advanz. HPRA shows March 2027 return date | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| PARALIEF 500MG EFF TABS PARACETAMOL | 12TABS | TBC | CLONMEL | 11-May-26 | 22-May-26 | Manufacturing delay | PARACETAMOL | As per Clonmel | |||
| PARALIEF 500MG EFF TABS PARACETAMOL | 24TABS | TBC | CLONMEL | 12-May-26 | 07-Jul-26 | Manufacturing delay | PARACETAMOL | As per Clonmel | |||
| PEGASYS 135MCG SOLN FOR INJ PFS | 1SYR | 88365 | In Stock | PHARMA | 21-Jul-26 | 05-Aug-26 | 05-Aug-26 | Shipping delay/ distribution issue | INTERFERON ALFA-2A | No longer on HPRA list | Not reimbursed - alternative strengths available on the reimbursement list |
| PEMETREXED ACCORD 25MG/ML CONC INF 34ML | 1VIAL | TBC | ACCORD HC | 06-Feb-26 | 27-Mar-26 | Manufacturing delay | PEMETREXED | As per Accord | |||
| PENDREX 2MG TABS PERINDOPRIL | 30TABS | 76800 | 19th August 2026 | ROWA | 17-Jul-26 | 11-Aug-26 | Delayed delivery | PERINDOPRIL ERBUMINE | As per Rowa | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| PENDREX 4MG TABS PERINDOPRIL | 30TABS | 76883 | OOS expected w/c 31st August. Return date End October 2026 | ROWA | 13-Aug-26 | Increase in sales | PERINDOPRIL ERBUMINE | As per Rowa | |||
| PENTASA 500MG PROLONGED RELEASE TABS | 100TABS | 59080 | In Stock | FERRING | 03-Jun-26 | 23-Jul-26 | 23-Jul-26 | Manufacturing delay | MESALAZINE | No longer on HPRA list | Not reimbursed - alternative therapeutic options available on the reimbursement list |
| PENTASA SACHET 1G PRO REL GRANULES | 50SACH | 39066 | OOS expected 21st August. Return date 28th August 2026 | FERRING | 07-Aug-26 | Unexpected increased demand | MESALAZINE | As per HPRA | |||
| PERDAMEL 1MG FC TABS RISPERIDONE | 60TABS | 39523 | Early October 2026 | CLONMEL | 16-Jul-26 | 24-Jul-26 | API Shortage / unavailability | RISPERIDONE | As per Clonmel | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| PERINDOPRIL ARGININE CLONMEL 10MG FC TAB | 30TABS | 67242 | Pending | CLONMEL | 27-Jul-26 | 05-Aug-26 | API Shortage / unavailability | PERINDOPRIL ARGININE | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| PERINDOPRIL ARGININE CLONMEL 5MG FC TABS | 30TABS | 67241 | Pending | CLONMEL | 13-Aug-26 | Manufacturing delay | PERINDOPRIL ARGININE | As per HPRA | |||
| PERINDOPRIL TOS/INDAPAM TEVA 2.5/0.625MG | 30TABS | 39114 | TBC | TEVA | 04-Jun-26 | 16-Jun-26 | No reason provided | PERINDOPRIL TOSIL/INDAPAM | As per Teva | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| PERINDOPRIL TOS/INDAPAMIDE TEVA 10/2.5MG | 30TABS | 39122 | Back In Stock (awaiting release) | TEVA | 20-Mar-26 | 30-Jul-26 | 30-Jul-26 | Manufacturing delay | PERINDOPRIL TOSIL/INDAPAM | As per Teva | Not reimbursed - alternative therapeutic options available on the reimbursement list |
| PERINDOPRIL TOS/INDAPAMIDE TEVA 5/1.25MG | 30TABS | 39115 | Aug-26 | TEVA | 05-Jan-26 | 23-Jul-26 | Manufacturing delay | PERINDOPRIL TOSIL/INDAPAM | As per Teva | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| PERINDOPRIL TOSILATE TEVA 10MG FC TABS | 30TABS | 39110 | Aug-26 | TEVA | 26-Jun-26 | 06-Aug-26 | Manufacturing delay | PERINDOPRIL TOSILATE | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| PERINDOPRIL TOSILATE TEVA 5MG FC TABS | 30TABS | 39109 | Sep-26 | TEVA | 22-Jul-26 | 06-Aug-26 | Manufacturing delay | PERINDOPRIL TOSILATE | As per Teva | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| PINACORT 3MG MOD REL HARD CAPS | 100CAPS | 67118 | Unable to provide date | PINEWOOD | 03-Nov-25 | 24-Jul-26 | No reason provided | BUDESONIDE | As per Pinewood | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| PIRFENIDONE TEVA 801MG FC TABS | 84TABS | 89242 | OOS expected 18th August. Return date 1st October 2026 | TEVA | 04-Aug-26 | 11-Aug-26 | Manufacturing delay | PIRFENIDONE | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| PLERIXAFOR ACCORD 20MG/ML SOLN/INJ 1.2ML | 1VIAL | TBC | ACCORD HC | 23-Feb-26 | 27-Mar-26 | No reason provided | As per Accord | ||||
| PONSTAN 250MG CAPS | 100CAPS | 41580 | No return date. | CHEMIDEX | 17-Oct-25 | 08-Jul-26 | No reason provided | MEFENAMIC ACID | As per Essential Pharma (Chemidex) | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| PONSTAN 250MG CAPS | 500CAPS | 41572 | No return date. | CHEMIDEX | 17-Oct-25 | 08-Jul-26 | No reason provided | MEFENAMIC ACID | As per Essential Pharma (Chemidex) | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| PRASUGREL ACCORD 10MG FC TABS | 28TABS | 28920 | 15th August 2026 | ACCORD HC | 02-Jun-26 | 30-Jul-26 | Unexpected increased demand | PRASUGREL | As per Accord | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| PRASUGREL VIATRIS 10MG FC TABS | 28PACK | 37407 | TBC | VIATRIS | 15-Sep-25 | 24-Jun-26 | Manufacturing delay | PRASUGREL | As per Viatris | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| PREDNISOLONE 1MG TABS | 250TABS | 78304 | TBC | CLONMEL | 17-Jul-25 | 20-May-26 | Manufacturing delay | PREDNISOLONE | As per Clonmel | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| PREDNISOLONE 5MG SOLUBLE TABS | 30TABS | 51269 | Back In Stock | ADVANZ | 10-Mar-23 | 27-Jul-26 | 24-Jul-26 | Delivery delay | PREDNISOLONE SODIUM PHOS | As per Advanz | Not reimbursed - alternative therapeutic options available on the reimbursement list |
| PREGABALIN ACCORD 25MG HARD CAPS | 56CAPS | 65380 | TBC | ACCORD HC | 22-Jul-25 | 13-Jul-26 | Delayed | PREGABALIN | As per Accord | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| PREGABALIN SANDOZ GMBH 100MG HARD CAPS | 84CAPS | 36949 | 30th August 2026 | ROWA | 09-Jun-25 | 10-Jul-26 | Production delays | PREGABALIN | As per Rowa | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| PREGABALIN SANDOZ GMBH 150MG HARD CAPS | 56CAPS | 36951 | 30th September 2026 | ROWA | 10-Jul-26 | 22-Jul-26 | Manufacturing delay | PREGABALIN | As per Rowa | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| PREGABALIN SANDOZ GMBH 200MG HARD CAPS | 84CAPS | 36952 | Awaiting further update | ROWA | 20-Mar-25 | 20-May-26 | Delay due to packing line adjustments | PREGABALIN | As per Rowa | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| PREGABALIN SANDOZ GMBH 75MG HARD CAPS | 56CAPS | 36948 | TBC | ROWA | 08-Apr-26 | 20-May-26 | Increase in sales | PREGABALIN | As per Rowa | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| PREMARIN 0.625MG PRO REL TABS | 28TABS | 62063 | 24th August 2026 | PFIZER | 04-Aug-26 | 11-Aug-26 | Unexpected increased demand | CONJUGATED ESTROGENS | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| PRIMOVIST 0.25MMOL/ML SOLN/INJ 10ML PFS | 1SYR | 18th August 2026 | BAYER | 04-Jun-26 | 26-Jun-26 | Quality issue | GADOXETATE | As per HPRA | |||
| PROPESS 10MG VAGINAL DELIVERY SYSTEM | 5DEVICE | 21st August 2026 | FERRING | 28-Jul-26 | 11-Aug-26 | Manufacturing delay | DINOPROSTONE | As per HPRA | |||
| PROSTIN E2 1MG VAGINAL GEL | 1SYR | Mid August 2026 | PFIZER | 27-Mar-26 | 08-Jul-26 | API shortage / unavailability | DINOPROSTONE | As per Pfizer | |||
| PROSTIN E2 2MG VAGINAL GEL | 1SYR | Late August 2026 | PFIZER | 27-Mar-26 | 08-Jul-26 | API shortages / unavailability | DINOPROSTONE | As per Pfizer | |||
| QUESTRAN 4G/SACHET PDR FOR ORAL SUSP | 50SACH | 44329 | 31st October 2026 | ATHENA | 15-Jul-26 | 22-Jul-26 | Delivery delay | COLESTYRAMINE | As per HPRA. Athena advised this may come back into stock earlier. | EMP reimbursed for duration of HPRA registered shortage | |
| QUETEX 300MG FC TABS QUETIAPINE | 60TABS | 46043 | Back In Stock | ROWA | 17-Jul-26 | 31-Jul-26 | 30-Jul-26 | Manufacturing delay & current stock expired | QUETIAPINE | As per Rowa | EMP reimbursed for duration of HPRA registered shortage |
| QUETEX XR 200MG PRO REL TABS | 60TABS | 45168 | Oct-26 | ROWA | 03-Feb-25 | 20-May-26 | Pharmathen supply issues | QUETIAPINE | As per Rowa | EMP reimbursed for duration of HPRA registered shortage | |
| QUETEX XR 300MG PRO REL TABS | 60TABS | 45169 | No stock in Q1, Q2 or Q3 - We will have to wait until Q4 allocation | ROWA | 14-Jun-24 | 06-Jul-26 | Pharmathen supply issues | QUETIAPINE | As per Rowa | EMP reimbursed for duration of HPRA registered shortage | |
| QUETEX XR 50MG PRO REL TABS | 60TABS | 46021 | No stock in Q1, Q2 or Q3 - We will have to wait until Q4 allocation | ROWA | 26-Mar-25 | 20-May-26 | Pharmathen supply issues | QUETIAPINE | As per Rowa | EMP reimbursed for duration of HPRA registered shortage | |
| QUETIAPINE 200MG FC TABS | 60TABS | 46088 | Discontinued (May 26) | ACCORD HC | 24-Feb-26 | 27-Jul-26 | 27-Jul-26 | No reason provided | As per Accord | EMP reimbursed for duration of HPRA registered shortage | |
| QUETIAPINE 300MG FC TABS | 60TABS | 46089 | Discontinued (May 26) | ACCORD HC | 24-Feb-26 | 27-Jul-26 | 27-Jul-26 | No reason provided | As per Accord | EMP reimbursed for duration of HPRA registered shortage | |
| QUETIAPINE KRKA 300MG FC TABS | 60TABS | 46023 | End August 2026 | KRKA PHARM | 18-Feb-26 | 16-Jun-26 | No reason provided | QUETIAPINE | As per KRKA | EMP reimbursed for duration of HPRA registered shortage | |
| RAMITACE 2.5MG TABS RAMIPRIL | 28TABS | 43065 | Pending | CLONMEL | 13-Aug-26 | Manufacturing delay | RAMIPRIL | As per HPRA | |||
| RELISTOR 12MG/0.6ML SOLN FOR INJ | 1VIAL | 43711 | 14th August 2026 | BAUSCH HEA | 24-Jul-26 | 10-Aug-26 | Shipping delay / distribution issue | METHYLNALTREXONE | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| REVATIO 0.8MG/ML SOLN FOR INJ 20ML | 1VIAL | 25th August 2026 | VIATRIS | 04-Aug-26 | Manufacturing delay | SILDENAFIL | As per HPRA | ||||
| RINOZAL 5MG FC TABS LEVOCETIRIZINE | 30TABS | 77801 | TBC | CLONMEL | 11-Mar-26 | 22-May-26 | Regulatory issue | LEVOCETIRIZINE | As per Clonmel | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| RISONTEL 35MG ONCE A WEEK TABS RISEDRONA | 4TABS | 50703 | End October 2026 | CLONMEL | 12-Jun-26 | 24-Jul-26 | Manufacturing delay | RISEDRONATE SODIUM | As per Clonmel | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| RISPEVA 0.5MG FC TABS RISPERIDONE | 20TABS | 44600 | Aug-26 | TEVA | 06-Jul-26 | 30-Jul-26 | Manufacturing delay | RISPERIDONE | As per Teva | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| RISPEVA 1MG FC TABS RISPERIDONE | 20TABS | 45309 | Sep-26 | TEVA | 11-Feb-26 | 13-Aug-26 | No reason provided | RISPERIDONE | As per Teva | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| RISPEVA 1MG FC TABS RISPERIDONE | 60TABS | 45337 | Sep-26 | TEVA | 11-Jun-26 | 13-Aug-26 | Manufacturing delay | RISPERIDONE | As per Teva | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| RISPEVA 3MG FC TABS RISPERIDONE | 60TABS | 45372 | Back In Stock (awaiting release) | TEVA | 04-Jul-26 | 23-Jul-26 | 23-Jul-26 | Manufacturing delay | RISPERIDONE | As per Teva | Not reimbursed - alternative therapeutic options available on the reimbursement lis |
| RIVAROXABAN ACCORD 20MG FC TABS | 28TABS | 67371 | In Stock | ACCORD HC | 13-Jul-26 | 29-Jul-26 | 29-Jul-26 | Shipping delay / distribution issue | RIVAROXABAN | No longer on HPRA list | Not reimbursed - alternative therapeutic options available on the reimbursement list |
| ROLYPREXA 5MG FC TABS OLANZAPINE | 28TABS | 32971 | OOS expected w/c 24th August. Return date TBC | ROWA | 07-Aug-26 | 11-Aug-26 | Delayed delivery | OLANZAPINE | As per Rowa | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| ROSUVASTATIN VIATRIS 10MG FC TABS | 28TABS | 62866 | Sep-26 | VIATRIS | 01-Apr-26 | 20-May-26 | Manufacturing delay | ROSUVASTATIN | As per Viatris | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| ROSUVASTATIN VIATRIS 20MG FC TABS | 28TABS | 62867 | Sep-26 | VIATRIS | 01-Apr-26 | 20-May-26 | Manufacturing delay | ROSUVASTATIN | As per Viatris | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| ROSUVASTATIN VIATRIS 40MG FC TABS | 28TABS | 62868 | OOS expected 17th August. Return date 2nd November 2026 | VIATRIS | 06-Jul-26 | 05-Aug-26 | Manufacturing delay | ROSUVASTATIN | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| ROSUVASTATIN VIATRIS 5MG FC TABS | 28TABS | 62865 | 2nd November 2026 | VIATRIS | 06-Jul-26 | 20-Jul-26 | Manufacturing delay | ROSUVASTATIN | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| SAMETEC AIRMASTER 50MCG/250MCG 60 DOSE | 1DISK | 34458 | TBC | CLONMEL | 04-Jun-26 | 16-Jun-26 | Manufacturing delay | SALMETEROL/FLUTICASO PROP | As per Clonmel | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| SAVLON ANTISEPTIC CREAM | 30G | TBC | CLONMEL | 10-Jun-26 | 07-Jul-26 | No reason provided | CETRIMIDE/CHLORHEXIDINE | As per HPRA | |||
| SAVLON ANTISEPTIC CREAM | 60G | TBC | CLONMEL | 14-Nov-25 | 10-Jun-26 | Manufacturing delay | CETRIMIDE/CHLORHEXIDINE | As per Clonmel. | |||
| SEROPIA 200MG FC TABS QUETIAPINE | 60TABS | 46070 | Mid August 2026 | CLONMEL | 07-Jul-26 | 24-Jul-26 | No reason provided | QUETIAPINE | As per Clonmel | EMP reimbursed for duration of HPRA registered shortage | |
| SEROPIA XR 150MG PRO REL TABS QUETIAPINE | 60TABS | 46096 | End August 2026 | CLONMEL | 22-Oct-24 | 10-Jun-26 | No reason provided | QUETIAPINE | As per Clonmel | EMP reimbursed for duration of HPRA registered shortage | |
| SEROPIA XR 200MG PRO REL TABS QUETIAPINE | 60TABS | 46097 | Mid August 2026 | CLONMEL | 13-Apr-26 | 24-Jul-26 | No reason provided | QUETIAPINE | As per Clonmel | EMP reimbursed for duration of HPRA registered shortage | |
| SEROPIA XR 300MG PRO REL TABS QUETIAPINE | 60TABS | 46098 | End August 2026 | CLONMEL | 10-Jun-24 | 10-Jun-26 | No reason provided | QUETIAPINE | As per Clonmel (HPRA shows 31.07.26 return date) | EMP reimbursed for duration of HPRA registered shortage | |
| SEROPIA XR 50MG PRO REL TABS QUETIAPINE | 60TABS | 46095 | End August 2026 | CLONMEL | 13-Jan-25 | 10-Jun-26 | Manufacturing delay | QUETIAPINE | As per Clonmel | EMP reimbursed for duration of HPRA registered shortage | |
| SEROQUEL XR 150MG PRO REL TABS ORIGINAL | 60TABS | No resupply date | ORIGINALIS | 18-Nov-25 | Low sales price in Ireland and demand | QUETIAPINE | As per Originals | ||||
| SEROQUEL XR 200MG PRO REL TABS PCO | 60TABS | 66923 | Intermittent supply - Limited supply | PCO | 12-Nov-25 | 22-May-26 | No reason provided | QUETIAPINE | As per PCO | EMP reimbursed for duration of HPRA registered shortage | |
| SEROQUEL XR 400MG PRO REL TABS ORIGINAL | 60TABS | 31142 | No resupply date | ORIGINALIS | 18-Nov-25 | 20-May-26 | Low sales price in Ireland and demand | QUETIAPINE | As per Originalis | EMP reimbursed for duration of HPRA registered shortage | |
| SEROQUEL XR 50MG PRO REL TABS | 60TABS | 45812 | No return date at present | ATHENA | 14-Aug-26 | Unexpected increased demand | QUETIAPINE | As per Athena / HPRA | |||
| SEROQUEL XR 50MG PRO REL TABS PCO | 60TABS | 29216 | No return to stock date | PCO | 12-Nov-25 | 15-Jul-26 | No reason provided | QUETIAPINE | As per PCO | EMP reimbursed for duration of HPRA registered shortage | |
| SERTRALINE KRKA 100MG FC TABS | 28TABS | 50561 | 2026 | KRKA PHARM | 19-Nov-25 | 20-May-26 | No reason provided | SERTRALINE | As per KRKA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| SERTRALINE KRKA 50MG FC TABS | 28TABS | 50560 | 2026 | KRKA PHARM | 19-Nov-25 | 20-May-26 | No reason provided | SERTRALINE | As per KRKA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| SILCARFIL 20MG FC TABS SILDENAFIL | 90TABS | 88455 | End September 2026 | ROWA | 10-Jul-26 | 14-Jul-26 | Increase in sales | SILDENAFIL | As per Rowa | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| SIMVASTATIN TEVA 20MG FC TABS | 28TABS | 38247 | TBC | TEVA | 08-Apr-26 | 20-May-26 | Manufacturing delay | SIMVASTATIN | As per Teva | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| SITAGLIPTIN VIATRIS 100MG FC TABS | 28TABS | 66985 | 17th August 2026 | VIATRIS | 10-Apr-26 | 29-Jul-26 | Manufacturing delay | SITAGLIPTIN | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| SITAGLIPTIN VIATRIS 50MG FC TABS | 28TABS | 66984 | Q4 2026 | VIATRIS | 02-Jun-26 | 16-Jun-26 | Unexpected increased demand | SITAGLIPTIN | As per Viatris | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| SITAGLIPTIN/METFORMIN 50/850MG FC TABS | 56TABS | 67043 | Back In Stock | CLONMEL | 07-Jul-26 | 24-Jul-26 | 24-Jul-26 | No reason provided | SITAGLIPTIN/METFORMIN | As per Clonmel | Not reimbursed - alternative therapeutic options available on the reimbursement list |
| SOLIFENACIN SUCCINATE 5MG FC TABS | 30TABS | 29217 | Sep-26 | ACCORD HC | 16-Apr-26 | 07-Aug-26 | Shipping delay / distribution issue | SOLIFENACIN | As per Accord | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| SOLPADOL CAPLETS 500MG/30MG TABS | 100TABS | 47082 | BSR stock available. | PHOENIX | 24-Feb-26 | 08-Jul-26 | Shipping delay / distribution issue | PARACETAMOL/CODEINE PHOS | As per Phoenix. Awaiting info n return date for Irish licensed pack | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| SOLU-MEDRONE 500MG PDR + SOLV/SOLN/INJ | 1VIAL | 17th August 2026 | PFIZER | 27-Jul-26 | 11-Aug-26 | Manufacturing delay | METHYLPREDNISOLO SOD SUCC | As per HPRA | |||
| SORMON 60MG PRO REL TABS ISOSORBIDE | 28TABS | 72058 | 7th September 2026 | VIATRIS | 20-Jul-26 | 21-Jul-26 | Unexpected demand | ISOSORBIDE MONONITRATE | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| SPERIZAK 25MG PDR + SOLV PROREL SUSP/INJ | 1VIAL | 37426 | No return date | ACCORD HC | 23-Jul-25 | 20-May-26 | Shipping delay / distribution issue | RISPERIDONE | As per Accord. | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| SPERIZAK 37.5MG PDR + SOLV PROREL INJ | 1VIAL | 37428 | No return date | ACCORD HC | 23-Jul-25 | 20-May-26 | Shipping delay / distribution issue | RISPERIDONE | As per Accord. | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| SPERIZAK 50MG PDR + SOLV PROREL INJ | 1VIAL | 37429 | TBC Issue at Site | ACCORD HC | 23-Jul-25 | 20-May-26 | Shipping delay / distribution issue | RISPERIDONE | As per Accord. (HPRA shows Pendig return date) | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| SPIRONOLACTONE 100MG FC TABS | 100TABS | 72816 | TBC | ACCORD HC | 23-Feb-26 | 13-Jul-26 | Delayed | SPIRONOLACTONE | As per Accord | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| STELAZINE 1MG TABS | 112TABS | No confirmed timeline (short dated stock may be available) | ADVANZ | 05-Jun-26 | Manufacturing delay | TRIFLUOPERAZINE | As per Advanz | ||||
| SUMATRAN 100MG TABS SUMATRIPTAN | 6TABS | 68374 | Back In Stock | ROWA | 20-Mar-26 | 17-Jul-26 | 17-Jul-26 | Increase in sales | SUMATRIPTAN | As per Rowa | Not reimbursed - alternative therapeutic options available on the reimbursement list |
| SUMATRAN 100MG TABS SUMATRIPTAN | 6TABS | 68374 | OOS expected w/c 24th August. Return date TBC | ROWA | 13-Aug-26 | Unprecedented demand | SUMATRIPTAN | As per Rowa | |||
| SUMATRAN 50MG TABS SUMATRIPTAN | 6TABS | 68359 | 30th October 2026 | ROWA | 08-Apr-26 | 17-Jul-26 | Increased demand | SUMATRIPTAN | As per Rowa | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| SUMATRIPTAN 100MG FC TABS | 6TABS | 36909 | No return date | ACCORD HC | 05-Feb-26 | 20-May-26 | Manufacturing delay | SUMATRIPTAN | As per Accord | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| SUMATRIPTAN 50MG FC TABS | 6TABS | 36908 | No return date | ACCORD HC | 05-Feb-26 | 20-May-26 | Manufacturing delay | SUMATRIPTAN | As per Accord | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| TAMSULOSIN 400MCG MOD REL HARD CAPS | 30CAPS | 50348 | 30th October 2026 | VIATRIS | 20-Jul-26 | 11-Aug-26 | Unexpected increased demand | TAMSULOSIN | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| TELMISARTAN CLONMEL 40MG FC TABS | 28TABS | 64423 | TBC | CLONMEL | 13-Apr-26 | 20-May-26 | No reason provided | TELMISARTAN | As per Clonmel | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| TELMISARTAN CLONMEL 80MG FC TABS | 28TABS | 64424 | TBC | CLONMEL | 13-Apr-26 | 20-May-26 | No reason provided | TELMISARTAN | As per Clonmel | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| TELMISARTAN HCTZ ROWA 80MG/12.5MG TABS | 28TABS | 13164 | July / August 2026 | ROWA | 04-May-26 | 22-May-26 | Unexpected increased demand | TELMISARTAN/HCTZ | As per Rowa | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| TENDROTIL SR 2MG PRO REL HARD CAPS | 28CAPS | 31598 | No return date | ACCORD HC | 04-Feb-25 | 20-May-26 | Quality issue | TOLTERODINE | As per Accord. | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| TENDROTIL SR 4MG PRO REL HARD CAPS | 28CAPS | 31643 | No return date | ACCORD HC | 17-Dec-24 | 20-May-26 | Quality issue | TOLTERODINE | As per Accord. | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| TETRIDAR 20MCG/80MCL SOLN FOR INJ PFP | 1PENS | 89028 | Back In Stock | TEVA | 08-Apr-26 | 13-Aug-26 | 13-Aug-26 | Manufacturing delay | TERIPARATIDE | As per Teva | Not reimbursed - alternative therapeutic options available on the reimbursement list |
| TEVAQUEL 100MG FC TABS QUETIAPINE | 60TABS | 46053 | Back In Stock (awaiting release) | TEVA | 09-Apr-26 | 23-Jul-26 | 23-Jul-26 | Manufacturing delay | QUETIAPINE | As per Teva | EMP reimbursed for duration of HPRA registered shortage |
| TEVAQUEL 200MG FC TABS QUETIAPINE | 60TABS | 46054 | Sep-26 | TEVA | 10-Apr-26 | 13-Aug-26 | Manufacturing delay | QUETIAPINE | As per Teva | EMP reimbursed for duration of HPRA registered shortage | |
| TEVAQUEL XL 300MG PRO REL TAB QUETIAPINE | 60TABS | 67832 | Sep-26 | TEVA | 23-Jun-25 | 13-Aug-26 | Manufacturing delay | QUETIAPINE | As per Teva | EMP reimbursed for duration of HPRA registered shortage | |
| TEVAQUEL XL 50MG PRO REL TABS QUETIAPINE | 60TABS | 65982 | Oct-26 | TEVA | 24-Nov-25 | 06-Aug-26 | Manufacturing delay | QUETIAPINE | As per Teva | EMP reimbursed for duration of HPRA registered shortage | |
| TIPOL 125MG SUPPOSITORIES PARACETAMOL | 10SUPPOS | 68183 | Mid August 2026 | CLONMEL | 11-Mar-26 | 24-Jul-26 | Manufacturing delay | PARACETAMOL | As per Clonmel | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| TIPOL 500MG SUPPOSITORIES PARACETAMOL | 10SUPPOS | 68472 | Mid August 2026 | CLONMEL | 22-May-26 | 24-Jul-26 | No reason provided | PARACETAMOL | As per Clonmel | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| TIPURIC 100MG TABS ALLOPURINOL | 100TABS | 11363 | Early November 2026 | CLONMEL | 06-Jul-26 | 24-Jul-26 | API shortage / unavailability | ALLOPURINOL | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| TIPURIC 300MG TABS ALLOPURINOL | 100TABS | 11398 | Early November 2026 | CLONMEL | 13-Apr-26 | 07-Jul-26 | No reason provided | ALLOPURINOL | As per Clonmel | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| TOBI 300MG/5ML NEBULISER SOLN | 56NEB | 88370 | In Stock | VIATRIS | 29-Jul-26 | 07-Aug-26 | 07-Aug-26 | Quality issue | TOBRAMYCIN | No longer on HPRA list | Not reimbursed - alternative therapeutic options available on the reimbursement list |
| TOLTERODINE TARTRATE 2MG FC TABS | 56TABS | 36894 | TBC | ACCORD HC | 20-Mar-25 | 08-Jul-26 | Manufacturing delay | TOLTERODINE | As per Accord | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| TOSTRAN 2% GEL | 60G | 73020 | Back In Stock | ADVANZ | 26-Jun-26 | 04-Aug-26 | 31-Jul-26 | Unexpected increase in demand | TESTOSTERONE | As per Advanz | Not reimbursed - alternative therapeutic options available on the reimbursement list |
| TOVIAZ 8MG PRO REL TABS | 28TABS | 47575 | 1st September 2026 | PFIZER | 06-Aug-26 | 13-Aug-26 | Unexpected increased demand | FESOTERODINE | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| TRACRIUM 10MG/ML SOLN/INJ/INF 2.5ML AMPS | 5AMP | Awaiting update | SANDOZ | 16-Jan-26 | 01-Apr-26 | Manufacturing delay | ATRACURIUM | As per Rowa | |||
| TRAMADOL/PARACETAMOL KRKA 37.5/325MG TAB | 60TABS | 48591 | In Stock | KRKA PHARM | 28-Jul-26 | 05-Aug-26 | 05-Aug-26 | No reason provided | TRAMADOL/PARACETAMOL | No longer on HPRA list | |
| TRAMADOL/PARACETAMOL ROWA 37.5/325MG TAB | 60TABS | 48595 | 24th August 2026 | ROWA | 17-Jul-26 | 27-Jul-26 | Increased demand | TRAMADOL/PARACETAMOL | As per Rowa | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| TRAZODONE HCL 50MG/5ML ORAL SOLN | 120ML | 17224 | Back In Stock | KEY PHARMA | 23-Jun-26 | 31-Jul-26 | 30-Jul-26 | Shipping delay | TRAZODONE | As per Jed Pharma | |
| TRUSITEV SR 2MG PRO REL HARD CAPS | 28CAPS | 42046 | TBC | TEVA | 09-Jan-25 | 25-Jun-26 | No reason provided | TOLTERODINE | As per Teva | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| TRUSITEV SR 4MG PRO REL HARD CAPS | 28CAPS | 42052 | TBC | TEVA | 13-Feb-25 | 25-Jun-26 | No reason provided | TOLTERODINE | As per Teva | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| TYLEX 30MG/500MG HARD CAPS | 100CAPS | 50555 | In Stock | UCB PHARMA | 15-Jun-26 | 11-Aug-26 | 11-Aug-26 | Unexpected increased demand | CODEINE PHOS/PARACETAMOL | No longer on HPRA list | Not reimbursed - alternative therapeutic options available on the reimbursement list |
| TYVENSE 30MG HARD CAPS | 28CAPS | 45415 | In Stock | TAKEDA IRL | 15-Jul-26 | 14-Aug-26 | 13-Aug-26 | Unexpected increased demand | LISDEXAMFETAMINE | No longer on HPRA list | Not reimbursed - alternative therapeutic options available on the reimbursement list |
| TYVENSE 40MG HARD CAPS | 28TABS | 28755 | 23rd August 2026 | TAKEDA IRL | 20-Jul-26 | 11-Aug-26 | Unexpected increased demand | LISDEXAMFETAMINE | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| UROGRAFIN 30% SOLN FOR INF | 250ML | Pending | BAYER | 10-Mar-26 | 11-Aug-26 | Quality issue | SOD AMIDOTRI/MEGLUM AMIDO | As per HPRA | |||
| VALACICLOVIR BLUEFISH 500MG FC TABS | 30TABS | 60504 | 31st August 2026 | BLUEFISH | 18-Jun-26 | 08-Jul-26 | Manufacturing issues | VALACICLOVIR | As per Uniphar/Proluca. HPRA shows 1 Nov 26 return date | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| VALACICLOVIR TEVA 500MG FC TABS | 30TABS | 60563 | Back In Stock (awaiting release) | TEVA | 14-May-26 | 23-Jul-26 | 23-Jul-26 | Manufacturing delay | VALACICLOVIR | As per Teva | Not reimbursed - alternative therapeutic options available on the reimbursement list |
| VALOTIX 500MG FC TABS VALACICLOVIR | 10TABS | 51410 | Back In Stock | ROWEX | 17-Jun-26 | 31-Jul-26 | 30-Jul-26 | Increase in demand | VALACICLOVIR | As per Rowa | Not reimbursed - alternative therapeutic options available on the reimbursement list |
| VALOTIX 500MG FC TABS VALACICLOVIR | 30TABS | 67476 | In Stock | ROWEX | 17-Jun-26 | 27-Jul-26 | 27-Jul-26 | Now available | VALACICLOVIR | As per Rowa | Not reimbursed - alternative therapeutic options available on the reimbursement list |
| VALSARTAN HCTZ TEVA 160MG/12.5MG FC TABS | 28TABS | 73758 | OOS expected w/c 17th August. Return date 21st August 2026 | TEVA | 17-Jul-26 | 13-Aug-26 | Manufacturing delay | VALSARTAN/HCTZ | As per Teva | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| VALSARTAN TEVA 160MG FC TABS | 28TABS | 73735 | Back In Stock (awaiting release) | TEVA | 24-Apr-26 | 23-Jul-26 | 23-Jul-26 | Shipping delay / distribution issue | VALSARTAN | As per Teva | Not reimbursed - alternative therapeutic options available on the reimbursement list |
| VALTREX 500MG FC TABS IMED | 42TABS | No resupply date at present | IMED | 17-Jun-26 | 17-Jun-26 | Unexpected increased demand due to brand and generic OOS | VALACICLOVIR | As per IMED | |||
| VALTREX 500MG FC TABS PCO | 30TABS | 66944 | No return to stock date | PCO | 17-Jun-26 | 08-Jul-26 | No reason provided | VALACICLOVIR | As per PCO | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| VATAN 160MG FC TABS | 28TABS | 73796 | w/c 14th September 2026 | ROWA | 17-Jul-26 | 13-Aug-26 | Increased demand | VALSARTAN | As per Rowa | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| VENLOFEX 150MG PRO REL CAPS VENLAFAXINE | 28CAPS | 79172 | 30th November 2026 | VIATRIS | 04-Apr-25 | 15-Jun-26 | Manufacturing delay | VENLAFAXINE | As per Viatris | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| VIDENE 10% ALCOHOLIC TINCTURE | 500ML | Pending | ECOLAB | 19-Nov-25 | 05-Jan-26 | Manufacturing delay | POVIDONE-IODINE | As per HPRA | |||
| VIRALIEF 50MG/G CREAM ACICLOVIR | 2G | TBC | CLONMEL | 21-May-26 | 10-Jun-26 | Quality issue | ACICLOVIR | As per Clonmel | |||
| VISUDYNE 15MG PDR FOR SOLN/INF | 1VIAL | Back In Stock | ATHENA | 29-Mar-23 | 30-Jul-26 | 30-Jul-26 | Manufacturing delay | VERTEPORFIN | As per Athena | ||
| VITAFEN 100MG FC TABS | 60TABS | 35974 | Q3 2026 | PHOENIX | 15-Apr-25 | 22-Jul-26 | Awaiting approval on submission to the HPRA | ACECLOFENAC | As per Phoenix Labs. Exempt Medicinal Product avail. Temp code 55557 applies | Temporay code of 55557 | |
| WARFARIN TEVA 1MG TABS | 100TABS | 61701 | Back In Stock (awaiting release) | TEVA | 27-Apr-26 | 16-Jul-26 | 16-Jul-26 | Manufacturing delay | WARFARIN | As per Teva | temporary GMS Code of 55532 |
| XARELTO 1MG/ML GRANULES FOR ORAL SUSP | 51.7ML | 3rd August 2026 | BAYER | 15-Jun-26 | 29-Jun-26 | Unexpected increased demand | RIVAROXABAN | As per HPRA | |||
| XYMEL COMP 37.5MG/325MG FC TABS | 60TABS | 52750 | Mid September 2026 | CLONMEL | 07-Jul-26 | 20-Jul-26 | No reason provided | TRAMADOL/PARACETAMOL | As per Clonmel. HPRA shows 02.09.26 return date | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| YASMIN 0.03MG/3MG FC TABS | 21TABS | 53010 | 19th August 2026 | BAYER | 13-Aug-26 | Manufacturing delay | ETHINYLESTRAD/DROSPIREN | As per HPRA | |||
| ZADITEN 0.25MG/ML EYE DROPS SOLN | 5ML | 63281 | 15th February 2027 | LAB THEA | 11-Jul-25 | 12-Aug-26 | Quality issue | KETOTIFEN | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| ZANIDIP 20MG FC TABS | 28TABS | 63804 | 30th October 2026 | RECORDATI | 13-Aug-26 | Unexpected increased demand | LERCANIDIPINE | As per HPRA | |||
| ZESTAN 20MG TABS LISINOPRIL | 28TABS | 53814 | End August 2026 | CLONMEL | 06-Jul-26 | 05-Aug-26 | Manufacturing delay | LISINOPRIL | As per Clonmel | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| ZINDACLIN 1% GEL | 30G | 59816 | 30th September 2026 | ASPIRE PH | 06-Mar-23 | 25-May-26 | Distribution issue | CLINDAMYCIN | As per HPRA. EMP avail. HPRA shows PA23142/016/001 as Not Marketed May 2026 | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| ZINERYT 40MG+12 MG PDR/SOLVENT/CUT SOLN | 30ML | 91995 | TBC | ATHENA | 11-Mar-26 | 20-May-26 | Manufacturing delay | ERYTHROMYCIN/ZINC ACETATE | As per Athena | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| ZOFRAN 4MG FC TABS | 30TABS | 53163 | 17th September 2026 (ETA) | ROWEX | 08-May-26 | 07-Aug-26 | Increase in sales | ONDANSETRON | As per Rowa | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| ZOFRAN 4MG/2ML SOLN/INJ/INF | 10AMP | Awaiting update | ROWEX | 01-Oct-25 | 13-Mar-26 | Checking with site to see what delay is with receiving stock | ONDANSETRON | As per Rowa | |||
| ZOFRAN 8MG FC TABS | 30TABS | 53155 | 17th September 2026 (ETA) | ROWEX | 05-Jun-26 | 07-Aug-26 | Manufacturing delay | ONDANSETRON | As per Rowa | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| ZOLEDRONIC ACID TEVA 4MG/5ML CONC/INF | 1VIAL | Sep-26 | TEVA | 09-Apr-26 | 09-Jul-26 | Unexpected increased demand | ZOLEDRONIC ACID | As per Teva | |||
| ZOLSKETIL PEGYLATED LIPOSOMO 2MG/ML 10ML | 1VIAL | Back In Stock | ACCORD HC | 15-Jul-26 | 07-Aug-26 | 07-Aug-26 | Manufacturing delay | DOXORUBICIN LIPOSOMAL | As per Accord | ||
| ZOLSKETIL PEGYLATED LIPOSOMO 2MG/ML 25ML | 1VIAL | 15th September 2026 | ACCORD HC | 15-Jul-26 | 17-Jul-26 | Manufacturing delay | DOXORUBICIN LIPOSOMAL | As per HPRA | |||
| ZYPADHERA 210MG PDR & SOLV PR SUSP/INJ | 1VIAL | 7th September 2026 | CHEPLAPHRM | 15-Jul-26 | 14-Aug-26 | Shipping delay / distribution issue | OLANZAPINE | As per HPRA | |||
| ZYPADHERA 300MG PDR & SOLV PR SUSP/INJ | 1VIAL | 9th September 2026 | CHEPLAPHRM | 27-Jul-26 | 11-Aug-26 | Unexpected increased demand | OLANZAPINE | As per HPRA | |||
| ZYPADHERA 405MG PDR & SOLV PR SUSP/INJ | 1VIAL | 18th August 2026 | CHEPLAPHRM | 28-May-26 | 14-Aug-26 | Manufacturing delay | OLANZAPINE | As per Athena | |||
| ZYPREXA 10MG VELOTAB TABS | 28TABS | 54726 | 30th November 2026 | CHEPLAPHRM | 25-Jun-26 | 08-Jul-26 | Unexpected increased demand | OLANZAPINE | As per HPRA | Not reimbursed - alternative therapeutic options available on the reimbursement list | |
| ZYPREXA 2.5MG TABS | 28TABS | 56049 | Back In Stock | CHEPLAPHRM | 04-Jun-26 | 14-Aug-26 | 14-Aug-26 | Manufacturing delay | OLANZAPINE | As per Athena | Not reimbursed - alternative therapeutic options available on the reimbursement list |
💊
Ask a question
about medicine shortages
about medicine shortages
By chatting, you agree to this
.
/* Mobile only */
@media (min-width: 769px) {
#medicineBubble,
#medicineChatWrapper {
display: none !important;
}
}
/* Centered bubble */
#medicineBubble {
position: fixed;
inset: 0;
margin: auto;
width: 100px;
height: 100px;
background: #8CC63F;
border-radius: 50%;
box-shadow: 0 10px 25px rgba(0,0,0,.3);
z-index: 999999;
display: flex;
align-items: center;
justify-content: center;
text-align: center;
color: #fff;
font-size: 11px;
font-weight: 600;
cursor: pointer;
}
#medicineBubble .icon {
font-size: 24px;
display: block;
margin-bottom: 4px;
}
/* Chat wrapper (hidden initially) */
#medicineChatWrapper {
display: none; /* MUST be hidden initially */
position: fixed;
inset: 0;
width: 100vw;
height: 100dvh;
flex-direction: column;
z-index: 1000000;
background: #fff;
overflow: hidden;
display: none;
}
#medicineChatHeader {
padding: calc(8px + env(safe-area-inset-top, 0px)) 12px 8px 12px;
display: flex;
justify-content: flex-end;
background: rgba(0,0,0,.05);
flex-shrink: 0;
}
#closeMedicineChat {
background: rgba(0,0,0,.85);
color: #fff;
border: none;
padding: 8px 12px;
border-radius: 999px;
font-size: 14px;
}
#medicineChatIframe {
flex: 1;
width: 100%;
border: none;
}
// Force chat hidden on page load
document.getElementById('medicineChatWrapper').style.display = 'none';
function openMedicineChat() {
document.getElementById('medicineChatWrapper').style.display = 'flex';
document.getElementById('medicineBubble').style.display = 'none';
document.body.style.overflow = 'hidden';
}
function closeMedicineChat() {
document.getElementById('medicineChatWrapper').style.display = 'none';
document.getElementById('medicineBubble').style.display = 'flex';
document.body.style.overflow = '';
}
💊
Ask a question
about medicine shortages
about medicine shortages
By chatting, you agree to this .
- Medicines Shortages List Aug 2026
- Medicines Shortages List July 2026
- Medicines Shortages List June 2026
- Medicines Shortages List May 2026
- Medicines Shortages List Apr 2026
- Medicines Shortages List Mar 2026
- Medicines Shortages List Feb 2026
- Medicines Shortages List Jan 2026
- Medicines Shortages List Dec 2025
- Medicines Shortages List Nov 2025
- Medicines Shortages List Oct 2025
- Medicines Shortages List Sep 2025